{
    "en_vn": {
        "data": {
            "content": "<div class=\"dict--title\">T\u1eeb \u0111i\u1ec3n Anh - Vi\u1ec7t</div><div class=\"dict--content\"><table id=\"definition\" border=\"0\"><tr id=\"pa\"><td id=\"I_C\"><font color=\"#9e9e9e\">\u25d8</font></td><td id=\"C_C\" colspan=\"2\"><font color=\"#9e9e9e\">[pleitlit]</font></td></tr><tr id=\"tl\"><td id=\"I_C\"><font color=\"#1a76bf\">*</font></td><td id=\"C_C\" colspan=\"2\"><b><font color=\"#1a76bf\">danh t\u1eeb</font></b></td></tr><tr id=\"mn\"><td>\u00a0</td><td id=\"I_C\"><font color=\"#999\">\u25a0</font></td><td id=\"C_C\">(y h\u1ecdc) ti\u1ec3u huy\u1ebft c\u1ea7u (ch\u1ea5t nh\u1ecf h\u00ecnh \u0111\u0129a \u1edf trong m\u00e1u gi\u00fap m\u00e1u \u0111\u00f3ng c\u1ee5c)</td></tr></table><i/></div>",
            "word": "platelet",
            "pronounce": "[pleitlit]"
        }
    },
    "en_en": {
        "data": {
            "content": "<div class=\"dict--title\">Anh - Anh</div><div class=\"dict--content\"><k>platelet</k><blockquote>\u25a0 <cclass>noun <cclass>Physiology a small colourless disc-shaped cell fragment without a nucleus, found in large numbers in blood and involved in clotting. </cclass></cclass></blockquote></div>",
            "word": "platelet",
            "pronounce": "[pleitlit]"
        }
    },
    "synonyms": {
        "data": {
            "content": null,
            "word": "platelet",
            "pronounce": "[pleitlit]"
        }
    },
    "grammar": {
        "data": {
            "content": null,
            "word": "platelet",
            "pronounce": "[pleitlit]"
        }
    },
    "specialist": {
        "data": {
            "content": "<div class=\"dict--title\">T\u1eeb \u0111i\u1ec3n K\u1ef9 thu\u1eadt (EN)</div><div class=\"dict--content\"><table cellspacing=\"0\" cellpadding=\"0\" border=\"0\"><tbody><tr><td/><td><font color=\"#999\">\u25a0</font><font>\u00a0t\u1ea5m m\u1ecfng</font></td></tr></tbody></table><table cellspacing=\"0\" cellpadding=\"0\" border=\"0\"><tbody><tr><td/><td><font color=\"#999\">\u25a0</font><font>\u00a0ti\u1ec3u c\u1ea7u</font></td></tr></tbody></table><table cellspacing=\"0\" cellpadding=\"0\" border=\"0\"><tbody><tr><td/><td><b><font color=\"#1a76bf\">L\u0129nh v\u1ef1c:</font></b><font color=\"#666699\"> h\u00f3a h\u1ecdc &amp; v\u1eadt li\u1ec7u</font></td></tr></tbody></table><table cellspacing=\"0\" cellpadding=\"0\" border=\"0\"><tbody><tr><td/><td><font color=\"#999\">\u25a0</font><font>\u00a0t\u1ea5m nh\u1ecf</font></td></tr></tbody></table></div>",
            "word": "platelet",
            "pronounce": "[pleitlit]"
        }
    },
    "sentences": [
        {
            "en": "<em>Platelet</em> clumping can cause small blood clots, growths on the heart valves (endocarditis) or inflammation of blood vessels that can block the blood supply to the heart and brain.",
            "vi": "C\u00e1c c\u1ee5c ti\u1ec3u huy\u1ebft c\u1ea7u c\u00f3 th\u1ec3 g\u00e2y ra c\u00e1c c\u1ee5c m\u00e1u \u0111\u00f4ng nh\u1ecf, ph\u00e1t tri\u1ec3n tr\u00ean c\u00e1c van tim (vi\u00eam n\u1ed9i t\u00e2m m\u1ea1c) ho\u1eb7c vi\u00eam c\u00e1c m\u1ea1ch m\u00e1u c\u00f3 th\u1ec3 ng\u0103n ch\u1eb7n vi\u1ec7c cung c\u1ea5p m\u00e1u \u0111\u1ebfn tim v\u00e0 n\u00e3o."
        },
        {
            "en": "<em>Platelet</em> clumping can cause small blood clots, growths on the heart valves (endocarditis) or inflammation of blood vessels that can block the blood supply to the heart and brain.",
            "vi": "C\u00e1c c\u1ee5c ti\u1ec3u huy\u1ebft c\u1ea7u c\u00f3 th\u1ec3 g\u00e2y ra c\u00e1c c\u1ee5c m\u00e1u \u0111\u00f4ng nh\u1ecf, ph\u00e1t tri\u1ec3n tr\u00ean c\u00e1c van tim (vi\u00eam n\u1ed9i t\u00e2m m\u1ea1c) ho\u1eb7c vi\u00eam c\u00e1c m\u1ea1ch m\u00e1u c\u00f3 th\u1ec3 ng\u0103n ch\u1eb7n vi\u1ec7c cung c\u1ea5p m\u00e1u \u0111\u1ebfn"
        },
        {
            "en": "Gum bacteria escape into bloodstream and increase risk of clots and heart attack         UK researchers have found another reason for us to keep brushing and flossing our teeth: the same gum bacteria that cause dental plaque can escape from the mouth into the bloodstream and trigger clots that increase risk of heart attack and heart disease.  The study that led to this finding was the work of University of Bristol researchers, in collaboration with scientists at the Royal College of Surgeons in Dublin, Ireland (also called the RCSI) and was presented Monday at the Society for General Microbiology's autumn meeting that is running from 6-9 September at the University of Nottingham, UK. Dr Howard Jenkinson, professor of Oral Microbiology at Bristol's School of Oral and Dental Science, presented the findings at the meeting. He said in a press statement that: \"Poor dental hygiene can lead to bleeding gums, providing bacteria with an escape route into the bloodstream, where they can initiate blood clots leading to heart disease.\"  He said we all need to be aware that it's not only diet, exercise, cholesterol and blood pressure that we should keep an eye on, but it's also important to have good dental hygiene to reduce our risk of heart problems. Tooth plaque and gum disease are what happens when Streptococcus bacteria build up in our mouths when we don't brush and floss regularly. Gum disease makes gums sore and they bleed, allowing the bacteria to get into the bloodstream. In their study, Jenkinson and colleagues found that once Streptococcus bacteria get into the bloodstream, they use a protein called PadA which sits on their outer surface, to hijack blood platelets and force them to clump together and make blood clots. Jenkinson described this as a \"selfish trick\" on the part of the bacteria, which completely encase themselves in a clump of platelets, enabling them to avoid detection by the host immune system, and also, to hide from antibiotics.  \"Unfortunately, as well as helping out the bacteria\", explained Jenkinson, \"<em>platelet</em> clumping can cause small blood clots, growths on the heart valves (endocarditis) or inflammation of blood vessels that can block the blood supply to the heart and brain\".  The team are now investigating how PadA makes blood platelets clump together so they can find a way to block it. They are doing it with the help of a new blood flow model that mimics the human circulatory system. The model was developed by Dr Steve Kerrigan of RCSI's School of Pharmacy. \"This could eventually lead to new treatments for cardiovascular disease which is the biggest killer in the developed world,\" said Jenkinson.  Dr Damian Walmsley, professor of Restorative Dentistry, in the School of Dentistry at the University of Birmingham, who is also scientific adviser to the British Dental Association, told the BBC that this kind of research is very welcome because it increases understanding of the relationship between gum disease and heart disease.  Walmsley said it also underlines \"the high importance of brushing twice a day with fluoride toothpaste, restricting your intake of sugary foods and drinks and visiting the dentist regularly in order to maintain good oral health\".  There are over 100 species and strains of bacteria in the Streptococcus genus, some so diverse they are considered species in their own right.  It wasn't until advances in genetics, such as genome sequencing, arrived in the lab that scientists were able to see the links among strains in the genus. As more links emerge, the more collaboration ensues between microbiologists who until then had no idea that others in apparently unrelated fields were actually working on the same problems. Jenkinson is also the organizer of the Streptococcus session of the Society for General Microbiology's Autumn Meeting, and in his notes about the symposium he wrote that it should not only provide an overview of \"this important research field\", but hopefully it will also \"re-engage microbiologists working on streptococci and related areas into a UK Streptococcus grouping (UKSTREP) for future benefit\". \"Oral streptococci behaving badly.\" Presented by Howard Jenkinson. Autumn Meeting of the Society for General Microbiology, 6 September 2010, Nottingham.  Sources: Bristol University, BBC News. Written by: Catharine Paddock, PhD  Copyright: Medical News Today",
            "vi": "Vi khu\u1ea9n n\u01b0\u1edbu r\u0103ng \u0111i v\u00e0o m\u1ea1ch m\u00e1u l\u00e0m t\u0103ng nguy c\u01a1 \u0111\u00f4ng m\u00e1u v\u00e0 \u0111au tim     C\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u Anh \u0111\u00e3 t\u00ecm th\u1ea5y m\u1ed9t l\u00fd do n\u1eefa \u0111\u1ec3 ch\u00fang ta n\u00ean \u0111\u00e1nh r\u0103ng v\u00e0 d\u00f9ng ch\u1ec9 nha khoa v\u00ea\u0323 sinh r\u0103ng mi\u1ec7ng, \u0111o\u0301 l\u00e0 vi khu\u1ea9n n\u01b0\u1edbu r\u0103ng g\u00e2y ra cao r\u0103ng c\u00f3 th\u00ea\u0309 tho\u00e1t kh\u1ecfi mi\u1ec7ng \u0111i v\u00e0o trong m\u00e1u va\u0300 g\u00e2y ra huy\u1ebft kh\u1ed1i l\u00e0m t\u0103ng nguy c\u01a1 truy\u0323 tim va\u0300 b\u1ec7nh tim. Nghi\u00ean c\u1ee9u \u0111\u00e3 d\u1eabn \u0111\u1ebfn k\u1ebft lu\u1eadn n\u00e0y l\u00e0 th\u00e0nh qu\u1ea3 c\u1ee7a c\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u thu\u1ed9c \u0110\u1ea1i h\u1ecdc Bristol, h\u1ee3p t\u00e1c v\u1edbi c\u00e1c nh\u00e0 khoa h\u1ecdc t\u1ea1i H\u1ecdc vi\u1ec7n Ph\u1eabu thu\u1eadt Ho\u00e0ng gia \u1edf Dublin, Ireland (c\u00f2n g\u1ecdi l\u00e0 RCSI) v\u00e0 \u0111\u00e3 \u0111\u01b0\u1ee3c b\u00e1o c\u00e1o h\u00f4m th\u1ee9 hai t\u1ea1i ky\u0300 h\u1ecdp mu\u0300a thu c\u1ee7a H\u1ed9i Vi sinh v\u1eadt h\u1ecdc \u0110\u1ea1i c\u01b0\u01a1ng di\u1ec5n ra t\u1eeb ng\u00e0y 6 \u0111\u1ebfn 9 th\u00e1ng 9 t\u1ea1i \u0110\u1ea1i h\u1ecdc Nottingham, V\u01b0\u01a1ng qu\u1ed1c Anh.  Ti\u1ebfn s\u0129 Howard Jenkinson, gi\u00e1o s\u01b0 vi sinh v\u1eadt h\u1ecdc \u0111\u01b0\u1eddng mi\u1ec7ng c\u1ee7a Khoa R\u0103ng Mi\u1ec7ng \u0110\u1ea1i h\u1ecdc Bristol, tr\u00ecnh b\u00e0y c\u00e1c k\u1ebft qu\u1ea3 n\u00e0y t\u1ea1i cu\u1ed9c h\u1ecdp. \u00d4ng ph\u00e1t bi\u1ec3u trong m\u1ed9t th\u00f4ng c\u00e1o b\u00e1o ch\u00ed: \"V\u00ea\u0323 sinh r\u0103ng mi\u1ec7ng k\u00e9m c\u00f3 th\u00ea\u0309 d\u1eabn \u0111\u1ebfn ch\u1ea3y m\u00e1u n\u01b0\u1edbu r\u0103ng, m\u01a1\u0309 cho vi khu\u1ea9n l\u1ed1i tho\u00e1t v\u00e0o m\u1ea1ch m\u00e1u, n\u01a1i chu\u0301ng c\u00f3 th\u00ea\u0309 t\u00e1c \u0111\u1ed9ng l\u00e0m \u0111\u00f4ng m\u00e1u d\u1eabn \u0111\u1ebfn b\u1ec7nh tim.\" \u00d4ng n\u00f3i r\u1eb1ng ch\u00fang ta c\u1ea7n ph\u1ea3i nh\u1eadn th\u1ee9c \u0111\u01b0\u1ee3c l\u00e0 kh\u00f4ng nh\u1eefng ph\u1ea3i quan t\u00e2m \u0111\u1ebfn ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng, t\u1eadp th\u1ec3 d\u1ee5c, cholesterol v\u00e0 huy\u1ebft \u00e1p, m\u00e0 cu\u0303ng ph\u1ea3i gi\u1eef v\u1ec7 sinh r\u0103ng mi\u1ec7ng t\u1ed1t \u0111\u1ec3 gi\u1ea3m nguy c\u01a1 v\u1ec1 c\u00e1c v\u1ea5n \u0111\u1ec1 tim m\u1ea1ch. M\u1ea3ng b\u00e1m r\u0103ng v\u00e0 b\u1ec7nh n\u01b0\u1edbu r\u0103ng l\u00e0 nh\u1eefng b\u1ec7nh s\u1ebd x\u1ea3y ra khi li\u00ean c\u1ea7u khu\u1ea9n Streptococcus ph\u00e1t tri\u1ec3n trong mi\u1ec7ng khi ch\u00fang ta kh\u00f4ng ch\u1ea3i r\u0103ng v\u00e0 du\u0300ng ch\u1ec9 nha khoa th\u01b0\u1eddng xuy\u00ean. B\u1ec7nh n\u01b0\u1edbu r\u0103ng l\u00e0m n\u01b0\u1edbu r\u0103ng \u0111au v\u00e0 ch\u1ea3y m\u00e1u, t\u1ea1o \u0111i\u1ec1u ki\u1ec7n cho vi khu\u1ea9n \u0111i v\u00e0o m\u00e1u. Trong nghi\u00ean c\u1ee9u, Jenkinson v\u00e0 c\u00e1c \u0111\u1ed3ng nghi\u1ec7p nh\u1eadn th\u1ea5y m\u1ed9t khi li\u00ean c\u1ea7u khu\u1ea9n Streptococcus v\u00e0o \u0111\u01b0\u1ee3c m\u00e1u, chu\u0301ng s\u1ebd s\u1eed d\u1ee5ng m\u1ed9t protein \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 PadA tr\u00ean b\u1ec1 m\u1eb7t ngo\u00e0i c\u1ee7a chu\u0301ng, \u0111\u1ec3 kh\u1ed1ng ch\u00ea\u0301 c\u00e1c ti\u1ec3u c\u1ea7u trong m\u00e1u v\u00e0 r\u00e0ng bu\u1ed9c c\u00e1c ti\u1ec3u c\u1ea7u n\u00e0y l\u1ea1i v\u1edbi nhau t\u1ea1o th\u00e0nh c\u1ee5c m\u00e1u \u0111\u00f4ng. Jenkinson m\u00f4 t\u1ea3 \u0111i\u1ec1u n\u00e0y nh\u01b0 l\u00e0 m\u1ed9t \"tro\u0300 b\u1ecbp b\u1ee3m\" tr\u00ean m\u1ed9t ph\u1ea7n c\u1ee7a c\u00e1c vi khu\u1ea9n, s\u1ebd ho\u00e0n to\u00e0n b\u1ecdc l\u1ea5y m\u00ecnh trong m\u1ed9t \u0111\u00e1m ti\u1ec3u c\u1ea7u, cho ph\u00e9p chu\u0301ng tr\u00e1nh b\u1ecb ph\u00e1t hi\u1ec7n b\u1edfi h\u1ec7 th\u1ed1ng mi\u1ec5n d\u1ecbch c\u1ee7a v\u1eadt ch\u1ee7, cu\u0303ng nh\u01b0 kh\u00f4ng b\u1ecb kh\u00e1ng sinh ti\u00eau di\u1ec7t. \"Th\u1eadt kh\u00f4ng may, c\u0169ng nh\u01b0 gi\u00fap c\u00e1c vi khu\u1ea9n\", Jenkinson gi\u1ea3i th\u00edch, \"c\u00e1c c\u1ee5c ti\u1ec3u huy\u1ebft c\u1ea7u c\u00f3 th\u1ec3 g\u00e2y ra c\u00e1c c\u1ee5c m\u00e1u \u0111\u00f4ng nh\u1ecf, ph\u00e1t tri\u1ec3n tr\u00ean c\u00e1c van tim (vi\u00eam n\u1ed9i t\u00e2m m\u1ea1c) ho\u1eb7c vi\u00eam c\u00e1c m\u1ea1ch m\u00e1u c\u00f3 th\u1ec3 ng\u0103n ch\u1eb7n vi\u1ec7c cung c\u1ea5p m\u00e1u \u0111\u1ebfn tim v\u00e0 n\u00e3o\". Nh\u00f3m nghi\u00ean c\u1ee9u \u0111ang t\u00ecm hi\u1ec3u l\u00e0m th\u1ebf n\u00e0o m\u00e0 PadA khi\u1ebfn c\u00e1c ti\u1ec3u c\u1ea7u m\u00e1u k\u1ebft l\u1ea1i v\u1edbi nhau \u0111\u1ec3 c\u00f3 th\u1ec3 t\u00ecm ra c\u00e1ch ng\u0103n ch\u1eb7n. H\u1ecd \u0111ang l\u00e0m \u0111i\u1ec1u \u0111\u00f3 v\u1edbi s\u1ef1 gi\u00fap \u0111\u1ee1 c\u1ee7a m\u1ed9t m\u00f4 h\u00ecnh m\u1edbi v\u00ea\u0300 d\u00f2ng ch\u1ea3y c\u1ee7a m\u00e1u b\u1eaft ch\u01b0\u1edbc theo h\u1ec7 th\u1ed1ng tu\u1ea7n ho\u00e0n c\u1ee7a con ng\u01b0\u1eddi. M\u00f4 h\u00ecnh n\u00e0y \u0111\u01b0\u1ee3c ph\u00e1t tri\u1ec3n b\u1edfi Ti\u1ebfn s\u0129 Steve Kerrigan c\u1ee7a Tr\u01b0\u1eddng D\u01b0\u1ee3c RCSI.  \"\u0110i\u1ec1u n\u00e0y cu\u1ed1i c\u00f9ng c\u00f3 th\u1ec3 d\u1eabn t\u1edbi nh\u1eefng ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb m\u1edbi cho b\u1ec7nh tim m\u1ea1ch \u2013 c\u0103n b\u1ec7nh gi\u1ebft ng\u01b0\u1eddi nhi\u1ec1u nh\u1ea5t trong th\u1ebf gi\u1edbi ph\u00e1t tri\u1ec3n,\" theo Jenkinson. Ti\u1ebfn s\u0129 Damian Walmsley, gi\u00e1o s\u01b0 Nha khoa Ph\u1ee5c h\u1ed3i, t\u1ea1i Tr\u01b0\u1eddng Nha khoa t\u1ea1i \u0110\u1ea1i h\u1ecdc Birmingham, c\u0169ng l\u00e0 c\u1ed1 v\u1ea5n khoa h\u1ecdc cho Hi\u1ec7p h\u1ed9i Nha khoa Anh Qu\u1ed1c, cho r\u1eb1ng lo\u1ea1i h\u00ecnh nghi\u00ean c\u1ee9u n\u00e0y r\u1ea5t \u0111\u01b0\u1ee3c hoan ngh\u00eanh b\u1edfi v\u00ec n\u00f3 giu\u0301p m\u1ecdi ng\u01b0\u1eddi hi\u1ec3u bi\u1ebft h\u01a1n v\u1ec1 m\u1ed1i quan h\u1ec7 gi\u1eefa b\u1ec7nh n\u01b0\u1edbu r\u0103ng v\u00e0 b\u1ec7nh tim. Walmsley cho bi\u1ebft nghi\u00ean c\u1ee9u n\u00e0y c\u0169ng nh\u1ea5n m\u1ea1nh \"t\u1ea7m quan tr\u1ecdng c\u1ee7a vi\u1ec7c \u0111\u00e1nh r\u0103ng hai l\u1ea7n m\u1ed9t ng\u00e0y v\u1edbi kem \u0111\u00e1nh r\u0103ng c\u00f3 ch\u1ee9a flor, h\u1ea1n ch\u1ebf ti\u00eau th\u1ee5 c\u00e1c lo\u1ea1i th\u1ef1c ph\u1ea9m v\u00e0 \u0111\u1ed3 u\u1ed1ng c\u00f3 \u0111\u01b0\u1eddng v\u00e0 \u0111i kh\u00e1m r\u0103ng th\u01b0\u1eddng xuy\u00ean \u0111\u1ec3 duy tr\u00ec s\u1ee9c kh\u1ecfe r\u0103ng mi\u1ec7ng t\u1ed1t.\" Hi\u1ec7n c\u00f3 h\u01a1n 100 lo\u00e0i v\u00e0 ch\u1ee7ng vi khu\u1ea9n trong chi li\u00ean c\u1ea7u khu\u1ea9n Streptococcus, m\u1ed9t s\u1ed1 r\u1ea5t kh\u00e1c nhau \u0111\u1ebfn n\u1ed7i ch\u00fang \u0111\u01b0\u1ee3c xem nh\u01b0 l\u00e0 c\u00e1c lo\u00e0i ri\u00eang bi\u1ec7t. M\u00e3i cho \u0111\u1ebfn khi c\u00f3 nh\u1eefng ti\u1ebfn b\u1ed9 trong di truy\u1ec1n h\u1ecdc nh\u01a1\u0300 v\u00e0o c\u00e1c cu\u1ed9c nghi\u00ean c\u1ee9u, ch\u1eb3ng h\u1ea1n nh\u01b0 tr\u00ecnh t\u1ef1 gen, c\u00e1c nh\u00e0 khoa h\u1ecdc m\u1edbi c\u00f3 th\u1ec3 nh\u1eadn th\u1ea5y s\u01b0\u0323 li\u00ean h\u00ea\u0323 gi\u1eefa c\u00e1c ch\u1ee7ng trong chi. Khi c\u00e1c li\u00ean k\u1ebft n\u00e0y ro\u0303 r\u00e0ng h\u01a1n, d\u1eabn \u0111\u1ebfn s\u01b0\u0323 c\u1ed9ng t\u00e1c gi\u1eefa c\u00e1c nha\u0300 vi tr\u00f9ng h\u1ecdc (nh\u1eefng ng\u01b0\u1eddi m\u00e0 m\u00e3i cho \u0111\u1ebfn khi n\u00e0y m\u1edbi nh\u1eadn ra kh\u00f4ng ch\u1ec9 c\u00f3 h\u1ecd nghi\u00ean c\u1ee9u v\u00ea\u0300 c\u00e1c lo\u00e0i vi khu\u1ea9n \u0111o\u0301 )v\u1edbi nh\u1eefng chuy\u00ean gia trong c\u00e1c l\u0129nh v\u1ef1c kh\u00e1c. Jenkinson c\u0169ng l\u00e0 ng\u01b0\u1eddi t\u1ed5 ch\u1ee9c cu\u1ed9c h\u1ecdp mu\u0300a thu chuy\u00ean \u0111\u00ea\u0300 v\u00ea\u0300 li\u00ean c\u1ea7u khu\u1ea9n Streptococcus c\u1ee7a H\u1ed9i Vi sinh v\u1eadt h\u1ecdc \u0110\u1ea1i c\u01b0\u01a1ng, v\u00e0 trong ghi ch\u00e9p c\u1ee7a m\u00ecnh v\u1ec1 c\u00e1c h\u1ed9i th\u1ea3o chuy\u00ean \u0111\u1ec1, \u00f4ng \u0111\u00e3 vi\u1ebft r\u1eb1ng hy v\u1ecdng cu\u1ed9c h\u1ecdp n\u00e0y s\u1ebd kh\u00f4ng ch\u1ec9 cung c\u1ea5p ki\u1ebfn th\u1ee9c t\u1ed5ng quan v\u1ec1 \"l\u0129nh v\u1ef1c nghi\u00ean c\u1ee9u quan tr\u1ecdng n\u00e0y\", m\u00e0 c\u00f2n m\u1ed9t l\u1ea7n n\u1eefa \u201cthu\u0301c \u0111\u1ea9y c\u00e1c nha\u0300 vi tru\u0300ng h\u1ecdc nghi\u00ean c\u1ee9u v\u00ea\u0300 li\u00ean c\u1ea7u khu\u1ea9n va\u0300 nh\u1eefng v\u1ea5n \u0111\u00ea\u0300 li\u00ean quan \u0111\u1ebfn n\u00f3 trong nh\u00f3m li\u00ean c\u1ea7u khu\u1ea9n \u1edf Li\u00ean hi\u1ec7p Anh cho nh\u1eefng l\u1ee3i \u00edch trong t\u01b0\u01a1ng lai\u201d. \"T\u00e1c h\u1ea1i c\u1ee7a li\u00ean c\u1ea7u khu\u1ea9n \u0111\u01b0\u1eddng mi\u1ec7ng\" Tr\u00ecnh b\u00e0y: Jenkinson Howard.  Phi\u00ean h\u1ecdp mu\u0300a thu c\u1ee7a H\u1ed9i Vi sinh v\u1eadt h\u1ecdc \u0110\u1ea1i c\u01b0\u01a1ng, ng\u00e0y 06 th\u00e1ng 9 n\u0103m 2010, Nottingham. Ngu\u1ed3n: \u0110\u1ea1i h\u1ecdc Bristol, BBC News. T\u00e1c gia\u0309: Catharine Paddock, Ti\u1ebfn s\u0129 B\u1ea3n quy\u1ec1n: Medical News Today"
        },
        {
            "en": "Stroke    What is a stroke? Stroke is a medical emergency and the third leading cause of death in the U.S. It occurs when a blood vessel in the brain bursts or, more commonly, when a blockage develops. Without treatment, cells in the brain quickly begin to die. The result can be serious disability or death. If a loved one is having stroke symptoms, seek emergency medical attention without delay.  Stroke symptoms Signs of a stroke may include: \u00a0\u00a0\u00a0 * Sudden numbness or weakness of the body, especially on one side. \u00a0\u00a0\u00a0 * Sudden vision changes in one or both eyes. \u00a0\u00a0\u00a0 * Sudden, severe headache with unknown cause. \u00a0\u00a0\u00a0 * Sudden problems with dizziness, walking, or balance. \u00a0\u00a0\u00a0 * Sudden confusion, difficulty speaking or understanding others. Call 911 immediately if you notice any of these symptoms. Stroke test: Talk, Wave, Smile The F.A.S.T. test helps spot symptoms. It stands for: Face. Ask for a smile. Does one side droop? Arms. When raised, does one side drift down? Speech. Can the person repeat a simple sentence?  Does he or she have trouble or slur words? Time. Time is critical. Call 911 immediately if any symptoms are present. Stroke: Time = Brain damage Every second counts when seeking treatment for a stroke. When deprived of oxygen, brain cells begin dying within minutes. There are clot-busting drugs that can curb brain damage, but they have to be used within three hours of the initial stroke symptoms. Once brain tissue has died, the body parts controlled by that area won't work properly. This is why stroke is a top cause of long-term disability. Diagnosing a stroke When someone with stroke symptoms arrives in the ER, the first step is to determine which type of stroke is occurring. There are two main types, and they are not treated the same way. A CT scan can help doctors determine whether the symptoms are coming from a blocked blood vessel or a bleeding one. Additional tests may also be used to find the location of a blood clot or bleeding within the brain. Ischemic stroke The most common type of stroke is known as an ischemic stroke. Nearly nine out of 10 strokes fall into this category. The culprit is a blood clot that obstructs a blood vessel inside the brain. The clot may develop on the spot or travel through the blood from elsewhere in the body. Hemorrhagic Stroke Hemorrhagic strokes are less common but far more likely to be fatal. They occur when a weakened blood vessel in the brain bursts. The result is bleeding inside the brain that can be difficult to stop. \u201cMini-Stroke\u201d (TIA) A transient ischemic attack, often called a \"mini-stroke,\" is more like a close call. Blood flow is temporarily impaired to part of the brain, causing symptoms similar to an actual stroke. When the blood flows again, the symptoms disappear. A TIA is a warning sign that a stroke may happen soon. It's critical to see your doctor if you think you've had a TIA. There are therapies to reduce the risk of stroke. What causes a stroke A common cause of stroke is atherosclerosis -- hardening of the arteries. Plaque made of fat, cholesterol, calcium, and other substances builds up in the arteries, leaving less space for blood to flow. A blood clot may lodge in this narrow space and cause an ischemic stroke. Atherosclerosis also makes it easier for a clot to form. Hemorrhagic strokes often result from uncontrolled high blood pressure that causes a weakened artery to burst. Risk factors: Chronic conditions Certain chronic conditions increase your risk of stroke. These include: \u00a0\u00a0\u00a0 * High blood pressure \u00a0\u00a0\u00a0 * High cholesterol \u00a0\u00a0\u00a0 * Diabetes \u00a0\u00a0\u00a0 * Obesity Taking steps to control these conditions may reduce your risk. Risk factors: Behaviors Certain behaviors also increase the risk of stroke: \u00a0\u00a0\u00a0 * Smoking \u00a0\u00a0\u00a0 * Getting too little exercise \u00a0\u00a0\u00a0 * Heavy use of alcohol Risk factors: Diet A poor diet may increase the risk for stroke in a few significant ways. Eating too much fat and cholesterol can lead to arteries that are narrowed by plaque. Too much salt may contribute to high blood pressure. And too many calories can lead to obesity. A diet high in fruits, vegetables, whole grains, and fish may help lower stroke risk. Risk factors you can't control Some stroke risk factors are beyond your control, such as getting older or having a family history of strokes. Gender plays a role, too, with men being more likely to have a stroke. However, more stroke deaths occur in women. Finally, race is an important risk factor. African-Americans, Native Americans, and Alaskan Natives are at greater risk compared to people of other ethnicities. Stroke: Emergency treatment For an ischemic stroke, emergency treatment focuses on medicine to restore blood flow. A clot-busting medication is highly effective at dissolving clots and minimizing long-term damage, but it must be given within three hours of the onset of symptoms. Hemorrhagic strokes are more difficult to manage. Treatment usually involves attempting to control high blood pressure, bleeding, and brain swelling. Stroke: Long-term damage Whether a stroke causes long-term damage depends on its severity and how quickly treatment stabilizes the brain. The type of damage depends on where in the brain the stroke occurs. Common problems after a stroke include numbness in the arms or legs, difficulty walking, vision problems, trouble swallowing, and problems with speech and comprehension. These problems can be permanent, but many people regain most of their abilities. Stroke rehab: Speech therapy Rehabilitation is the centerpiece of the stroke recovery process. It helps patients regain lost skills and learn to compensate for their damage. The goal is to help restore as much independence as possible. For people who have trouble speaking, speech and language therapy is essential. A speech therapist can also help patients who have trouble swallowing. Stroke rehab: Physical therapy Muscle weakness, as well as balance problems, are very common after a stroke. This can interfere with walking and other daily activities. Physical therapy is an effective way to regain strength, balance, and coordination. For fine motor skills, such as using a knife and fork, writing, and buttoning a shirt, occupational therapy can help. Stroke rehab: Talk therapy It's common for stroke survivors and their loved ones to experience a wide range of intense emotions, such as fear, anger, worry, and grief. A psychologist or mental health counselor can provide strategies for coping with these emotions. A therapist can also watch for signs of depression, which frequently strikes people who are recovering from a stroke. Stroke prevention: Lifestyle People who have had a stroke or TIA can take steps to prevent a recurrence: \u00a0\u00a0\u00a0 * Quit smoking. \u00a0\u00a0\u00a0 * Exercise and maintain a healthy weight. \u00a0\u00a0\u00a0 * Limit alcohol and salt intake. \u00a0\u00a0\u00a0 * Eat a healthier diet with more veggies, fish, and whole grains. Stroke prevention: Medications For people with a high risk of stroke, doctors often recommend medications to lower this risk. Anti-<em>platelet</em> medicines, including aspirin, keep platelets in the blood from sticking together and forming clots. Anti-clotting drugs, such as warfarin, may be needed to help ward off stroke in some patients. Finally, if you have high blood pressure, your doctor will prescribe medication to lower it. Stroke prevention: Surgery In some cases, a stroke results from a narrowed carotid artery -- the blood vessels that travel up each side of the neck to bring blood to the brain. People who have had a mild stroke or TIA due to this problem may benefit from surgery known as carotid endarterectomy. This procedure removes plaque from the lining of the carotid arteries and can prevent additional strokes. Stroke prevention: Balloon and Stent Doctors can also treat a clogged carotid artery without major surgery in some cases. The procedure, called angioplasty, involves temporarily inserting a catheter into the artery and inflating a tiny balloon to widen the area that is narrowed by plaque. A metal tube, called a stent, can be inserted and left in place to keep the artery open. Life after a stroke More than half of people who have a stroke regain the ability to take care of themselves. Those who get clot-busting drugs soon enough may recover completely. And those who experience disability can often learn to function independently through therapy. While the risk of a second stroke is higher at first, this risk drops off over time.",
            "vi": "\u0110\u1ed9t qu\u1ef5    \u0110\u1ed9t qu\u1ef5 l\u00e0 g\u00ec? \u0110\u1ed9t qu\u1ef5 l\u00e0 ch\u1ee9ng b\u1ec7nh nguy c\u1ea5p v\u00e0 l\u00e0 nguy\u00ean nh\u00e2n g\u00e2y t\u1eed vong l\u1edbn th\u1ee9 ba \u1edf M\u1ef9. B\u1ec7nh nh\u00e2n b\u1ecb \u0111\u1ed9t qu\u1ef5 khi b\u1ecb v\u1ee1 m\u1ea1ch m\u00e1u n\u00e3o ho\u1eb7c th\u01b0\u1eddng th\u1ea5y h\u01a1n l\u00e0 khi xu\u1ea5t hi\u1ec7n t\u1eafc ngh\u1ebdn m\u1ea1ch m\u00e1u \u1edf n\u00e3o. N\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb th\u00ec nh\u1eefng t\u1ebf b\u00e0o n\u00e3o s\u1ebd nhanh ch\u00f3ng b\u1eaft \u0111\u1ea7u ho\u1ea1i t\u1eed, \u0111\u1ec3 l\u1ea1i h\u1eadu qu\u1ea3 th\u01b0\u01a1ng t\u1eadt nghi\u00eam tr\u1ecdng ho\u1eb7c t\u1eed vong. N\u1ebfu ng\u01b0\u1eddi th\u00e2n c\u1ee7a m\u00ecnh c\u00f3 nh\u1eefng tri\u1ec7u ch\u1ee9ng \u0111\u1ed9t qu\u1ef5 th\u00ec b\u1ea1n n\u00ean \u0111\u01b0a \u0111i c\u1ea5p c\u1ee9u ngay t\u1ee9c kh\u1eafc.  C\u00e1c tri\u1ec7u ch\u1ee9ng c\u1ee7a \u0111\u1ed9t qu\u1ef5  D\u01b0\u1edbi \u0111\u00e2y l\u00e0 m\u1ed9t s\u1ed1 tri\u1ec7u ch\u1ee9ng c\u1ee7a \u0111\u1ed9t qu\u1ef5: * C\u01a1 th\u1ec3 \u0111\u1ed9t ng\u1ed9t b\u1ecb y\u1ebfu ho\u1eb7c t\u00ea c\u1ee9ng, nh\u1ea5t l\u00e0 m\u1ed9t b\u00ean ng\u01b0\u1eddi.\u00a0  * Th\u1ecb gi\u00e1c \u0111\u1ed9t ng\u1ed9t b\u1ecb thay \u0111\u1ed5i \u1edf m\u1ed9t ho\u1eb7c c\u1ea3 hai m\u1eaft.  * \u0110\u1ed9t ng\u1ed9t b\u1ecb nh\u1ee9c \u0111\u1ea7u d\u1eef d\u1ed9i m\u00e0 kh\u00f4ng t\u00ecm ra nguy\u00ean nh\u00e2n g\u00ec. * C\u01a1 th\u1ec3 \u0111\u1ed9t ng\u1ed9t b\u1ecb ch\u00f3ng m\u1eb7t, kh\u00f3 \u0111i \u0111\u1ee9ng ho\u1eb7c kh\u00f3 gi\u1eef th\u0103ng b\u1eb1ng.  * \u0110\u1ed9t ng\u1ed9t tr\u1edf n\u00ean hoang mang, m\u00f4 h\u1ed3, kh\u00f3 n\u00f3i chuy\u1ec7n ho\u1eb7c kh\u00f3 hi\u1ec3u \u0111\u01b0\u1ee3c ng\u01b0\u1eddi kh\u00e1c n\u00f3i g\u00ec.  B\u1ea1n h\u00e3y g\u1ecdi 911 ngay t\u1ee9c kh\u1eafc n\u1ebfu ph\u00e1t hi\u1ec7n b\u1ea5t k\u1ef3 tri\u1ec7u ch\u1ee9ng n\u00e0o tr\u00ean \u0111\u00e2y nh\u00e9. Ki\u1ec3m tra xem b\u1ec7nh nh\u00e2n c\u00f3 b\u1ecb \u0111\u1ed9t qu\u1ef5 hay kh\u00f4ng: N\u00f3i chuy\u1ec7n, l\u1eafc\u2013v\u1eaby (tay), c\u01b0\u1eddi  Ph\u01b0\u01a1ng ph\u00e1p x\u00e9t nghi\u1ec7m F.A.S.T. giu\u0301p t\u00ecm ra c\u00e1c tri\u1ec7u ch\u1ee9ng b\u1ec7nh, bao g\u1ed3m:  M\u1eb7t. H\u00e3y y\u00eau c\u1ea7u b\u1ec7nh nh\u00e2n c\u01b0\u1eddi \u0111\u1ec3 xem m\u1ed9t b\u00ean mi\u1ec7ng c\u00f3 b\u1ecb x\u1ec7 xu\u1ed1ng kh\u00f4ng?  C\u00e1nh tay. B\u1ea1n h\u00e3y \u0111\u1ec3 \u00fd xem khi \u0111\u01b0a tay l\u00ean cao, m\u1ed9t b\u00ean ng\u01b0\u1eddi b\u1ec7nh nh\u00e2n kh\u00f4ng th\u1ec3 nh\u1ea5c l\u00ean \u0111\u01b0\u1ee3c? N\u00f3i chuy\u1ec7n: Quan s\u00e1t xem ng\u01b0\u1eddi \u1ea5y c\u00f3 l\u1eb7p l\u1ea1i \u0111\u01b0\u1ee3c m\u1ed9t c\u00e2u ng\u1eafn g\u1ecdn kh\u00f4ng nh\u00e9; c\u00f3 kh\u00f3 kh\u0103n kh\u00f4ng hay c\u00f3 b\u1ecb n\u00f3i nh\u1ecbu, n\u00f3i l\u1eafp b\u1eafp kh\u00f4ng?  Th\u1eddi gian: Th\u1eddi gian \u0111\u1ed1i v\u1edbi b\u1ec7nh nh\u00e2n r\u1ea5t quan tr\u1ecdng. H\u00e3y g\u1ecdi 911 ngay n\u1ebfu ph\u00e1t hi\u1ec7n th\u1ea5y b\u1ea5t k\u1ef3 tri\u1ec7u ch\u1ee9ng g\u00ec k\u1ec3 tr\u00ean.  \u0110\u1ed9t qu\u1ef5: Th\u1eddi gian = T\u1ed5n th\u01b0\u01a1ng n\u00e3o  M\u1ed7i m\u1ed9t gi\u00e2y m\u1ed9t phu\u0301t c\u1ea7n \u0111\u1ebfn s\u1ef1 h\u1ed7 tr\u1ee3 c\u1ee7a y h\u1ecdc \u0111\u1ed1i v\u1edbi ch\u1ee9ng \u0111\u1ed9t qu\u1ef5 l\u00e0 h\u1ebft s\u1ee9c c\u1ea7n thi\u1ebft. Khi c\u00e1c t\u1ebf b\u00e0o n\u00e3o b\u1ecb thi\u1ebfu \u00f4-xy, chu\u0301ng s\u1ebd b\u1eaft \u0111\u1ea7u ho\u1ea1i t\u1eed trong th\u1eddi gian r\u1ea5t nhanh. Nhi\u1ec1u thu\u1ed1c ch\u1ed1ng huy\u1ebft kh\u1ed1i c\u00f3 th\u1ec3 giu\u0301p h\u1ea1n ch\u1ebf t\u1ed5n th\u01b0\u01a1ng n\u00e3o, nh\u01b0ng ph\u1ea3i \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng trong v\u00f2ng 3 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 sau khi b\u1ed9c ph\u00e1t c\u00e1c tri\u1ec7u ch\u1ee9ng \u0111\u1ed9t qu\u1ef5 \u0111\u1ea7u ti\u00ean. Khi m\u00f4 n\u00e3o \u0111\u00e3 b\u1ecb ho\u1ea1i t\u1eed th\u00ec c\u00e1c c\u01a1 quan do n\u00e3o \u0111i\u1ec1u ti\u1ebft trong c\u01a1 th\u1ec3 s\u1ebd kh\u00f4ng ho\u1ea1t \u0111\u1ed9ng t\u1ed1t n\u1eefa. \u0110\u00e2y l\u00e0 l\u00fd do v\u00ec sao \u0111\u1ed9t qu\u1ef5 l\u00e0 nguy\u00ean nh\u00e2n g\u00e2y th\u01b0\u01a1ng t\u1eadt v\u0129nh vi\u1ec5n h\u00e0ng \u0111\u1ea7u.\u00a0  Ch\u1ea9n \u0111o\u00e1n \u0111\u1ed9t qu\u1ef5  Khi b\u1ec7nh nh\u00e2n b\u1ecb c\u00e1c tri\u1ec7u ch\u1ee9ng \u0111\u1ed9t qu\u1ef5 v\u00e0o ph\u00f2ng c\u1ea5p c\u1ee9u th\u00ec b\u01b0\u1edbc \u0111\u1ea7u ti\u00ean l\u00e0 b\u00e1c s\u0129 ph\u1ea3i x\u00e1c \u0111\u1ecbnh xem ng\u01b0\u1eddi \u1ea5y b\u1ecb lo\u1ea1i \u0111\u1ed9t qu\u1ef5 n\u00e0o. C\u00f3 2 lo\u1ea1i \u0111\u1ed9t qu\u1ef5 ch\u00ednh v\u00e0 th\u01b0\u1eddng \u0111\u01b0\u1ee3c ch\u1eefa tr\u1ecb theo nh\u1eefng c\u00e1ch kh\u00e1c nhau. Ph\u01b0\u01a1ng ph\u00e1p s\u1eed d\u1ee5ng \u1ea3nh ch\u1ee5p c\u1eaft l\u1edbp (CT scan) c\u00f3 th\u1ec3 giu\u0301p b\u00e1c s\u0129 nh\u1eadn bi\u1ebft xem \u0111\u1ed9t qu\u1ef5 l\u00e0 do t\u1eafc ngh\u1ebdn m\u1ea1ch m\u00e1u hay l\u00e0 do xu\u1ea5t huy\u1ebft m\u1ea1ch m\u00e1u. Nhi\u1ec1u x\u00e9t nghi\u1ec7m b\u1ed5 sung kh\u00e1c cu\u0303ng c\u1ea7n thi\u1ebft \u0111\u1ec3 ph\u00e1t hi\u1ec7n v\u1ecb tr\u00ed m\u00e1u v\u00f3n c\u1ee5c ho\u1eb7c v\u1ecb tr\u00ed xu\u1ea5t huy\u1ebft n\u00e3o.\u00a0  \u0110\u1ed9t qu\u1ef5 do thi\u1ebfu m\u00e1u c\u1ee5c b\u1ed9 Lo\u1ea1i \u0111\u1ed9t qu\u1ef5 th\u01b0\u1eddng th\u1ea5y nh\u1ea5t l\u00e0 \u0111\u1ed9t qu\u1ef5 do thi\u1ebfu m\u00e1u c\u1ee5c b\u1ed9. G\u1ea7n 9/10 c\u00e1c ca \u0111\u1ed9t qu\u1ef5 \u0111\u1ec1u r\u01a1i v\u00e0o tr\u01b0\u1eddng h\u1ee3p n\u00e0y. Nguy\u00ean nh\u00e2n l\u00e0 do m\u00e1u v\u00f3n c\u1ee5c l\u00e0m t\u1eafc ngh\u1ebdn m\u1ea1ch m\u00e1u b\u00ean trong n\u00e3o. C\u1ee5c m\u00e1u \u0111\u00f4ng c\u00f3 th\u1ec3 n\u1eb1m ngay \u1edf n\u00e3o ho\u1eb7c di chuy\u1ec3n trong m\u00e1u t\u1eeb m\u1ed9t n\u01a1i n\u00e0o \u0111\u00f3 trong c\u01a1 th\u1ec3.  \u0110\u1ed9t qu\u1ef5 xu\u1ea5t huy\u1ebft  \u0110\u1ed9t qu\u1ef5 xu\u1ea5t huy\u1ebft \u00edt th\u1ea5y h\u01a1n nh\u01b0ng th\u01b0\u1eddng g\u00e2y t\u1ec9 l\u1ec7 t\u1eed vong cao h\u01a1n r\u1ea5t nhi\u1ec1u. Lo\u1ea1i \u0111\u1ed9t qu\u1ef5 n\u00e0y x\u1ea3y ra khi m\u1ed9t m\u1ea1ch m\u00e1u suy y\u1ebfu n\u00e0o \u0111\u00f3 trong n\u00e3o b\u1ecb v\u1ee1 \u0111i. H\u1eadu\u00a0 qu\u1ea3 l\u00e0 b\u1ec7nh nh\u00e2n b\u1ecb xu\u1ea5t huy\u1ebft b\u00ean trong n\u00e3o c\u00f3 th\u1ec3 r\u1ea5t kh\u00f3 ch\u1eefa l\u00e0nh.  \u201c\u0110\u1ed9t qu\u1ef5 nh\u1eb9/ \u0111\u1ed9t qu\u1ef5 tho\u00e1ng qua\u201d (TIA) C\u01a1n thi\u1ebfu m\u00e1u t\u1ea1m th\u1eddi th\u01b0\u1eddng \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 \u201cc\u01a1n \u0111\u1ed9t qu\u1ef5 tho\u00e1ng qua\u201d, t\u1ef1a nh\u01b0 m\u1ed9t s\u1ef1 tho\u00e1t hi\u1ec3m trong gang t\u1ea5c v\u1eady. S\u1ef1 l\u01b0u th\u00f4ng m\u00e1u \u0111\u1ebfn m\u1ed9t b\u1ed9 ph\u1eadn n\u00e3o b\u1ecb t\u1eafc ngh\u1ebdn t\u1ea1m th\u1eddi, g\u00e2y ra c\u00e1c tri\u1ec7u ch\u1ee9ng gi\u1ed1ng nh\u01b0 m\u1ed9t c\u01a1n \u0111\u1ed9t qu\u1ef5 th\u1eadt. Khi m\u00e1u \u0111\u01b0\u1ee3c l\u01b0u th\u00f4ng t\u1ed1t tr\u1edf l\u1ea1i th\u00ec nh\u1eefng tri\u1ec7u ch\u1ee9ng n\u00e0y bi\u1ebfn m\u1ea5t. TIA l\u00e0 d\u1ea5u hi\u1ec7u c\u1ea3nh b\u00e1o \u0111\u1ed9t qu\u1ef5 c\u00f3 th\u1ec3 s\u1ebd x\u1ea3y ra s\u1edbm \u0111\u1ea5y. Quan tr\u1ecdng l\u00e0 b\u1ea1n n\u00ean \u0111\u1ebfn b\u00e1c s\u0129 n\u1ebfu ngh\u0129 r\u1eb1ng m\u00ecnh b\u1ecb \u0111\u1ed9t qu\u1ef5 tho\u00e1ng qua. C\u00f3 nhi\u1ec1u li\u1ec7u ph\u00e1p giu\u0301p l\u00e0m gi\u1ea3m nguy c\u01a1 \u0111\u1ed9t qu\u1ef5.  Nguy\u00ean nh\u00e2n g\u00e2y \u0111\u1ed9t qu\u1ef5  Nguy\u00ean nh\u00e2n g\u00e2y \u0111\u1ed9t qu\u1ef5 th\u01b0\u1eddng th\u1ea5y l\u00e0 b\u1ec7nh x\u01a1 v\u1eefa \u0111\u1ed9ng m\u1ea1ch - x\u01a1 c\u1ee9ng \u0111\u1ed9ng m\u1ea1ch. M\u1ee1, cholesterol, can-xi, v\u00e0 nhi\u1ec1u ch\u1ea5t kh\u00e1c t\u1ee5 l\u1ea1i th\u00e0nh m\u1ea3ng b\u00e1m v\u00e0o \u0111\u1ed9ng m\u1ea1ch, l\u00e0m cho m\u00e1u l\u01b0u th\u00f4ng kh\u00f3 kh\u0103n h\u01a1n. C\u1ee5c m\u00e1u \u0111\u00f4ng c\u00f3 th\u1ec3 g\u00e2y t\u1eafc ngh\u1ebdn \u201c\u0111\u01b0\u1eddng \u0111i\u201d ch\u1eadt h\u1eb9p n\u00e0y v\u00e0 d\u1eabn \u0111\u1ebfn \u0111\u1ed9t qu\u1ef5 do thi\u1ebfu m\u00e1u c\u1ee5c b\u1ed9. Ch\u1ee9ng x\u01a1 v\u1eefa \u0111\u1ed9ng m\u1ea1ch cu\u0303ng c\u00f3 th\u1ec3 l\u00e0m cho m\u00e1u v\u00f3n d\u1ec5 d\u00e0ng h\u01a1n. \u0110\u1ed9t qu\u1ef5 do xu\u1ea5t huy\u1ebft th\u01b0\u1eddng l\u00e0 do huy\u1ebft \u00e1p cao kh\u00f4ng ki\u1ec3m so\u00e1t \u0111\u01b0\u1ee3c l\u00e0m cho \u0111\u1ed9ng m\u1ea1ch suy y\u1ebfu b\u1ecb v\u1ee1 \u0111i.  \u0111\u1ed9t qu\u1ef5 do b\u1ec7nh m\u00e3n t\u00ednh M\u1ed9t s\u1ed1 ch\u1ee9ng b\u1ec7nh m\u00e3n t\u00ednh c\u00f3 th\u1ec3 l\u00e0m t\u0103ng nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 bao g\u1ed3m:  * Cao huy\u1ebft \u00e1p * N\u1ed3ng \u0111\u1ed9 cholesterol cao  * Ti\u1ec3u \u0111\u01b0\u1eddng * B\u00e9o ph\u00ec Nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 c\u00f3 th\u1ec3 gi\u1ea3m \u0111i n\u1ebfu s\u1eed d\u1ee5ng bi\u1ec7n ph\u00e1p ki\u1ec3m so\u00e1t nh\u1eefng c\u0103n b\u1ec7nh n\u00e0y. \u0111\u1ed9t qu\u1ef5 do h\u00e0nh vi th\u00f3i quen B\u1ec7nh nh\u00e2n c\u00f3 th\u1ec3 t\u0103ng nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 n\u1ebfu m\u1eafc m\u1ed9t v\u00e0i h\u00e0nh vi sau:  * H\u00fat thu\u1ed1c * T\u1eadp th\u1ec3 d\u1ee5c qu\u00e1 \u00edt * S\u1eed d\u1ee5ng qu\u00e1 nhi\u1ec1u r\u01b0\u1ee3u bia  \u0110\u1ed9t qu\u1ef5 do ch\u1ebf \u0111\u1ed9 dinh d\u01b0\u1ee1ng  Ch\u1ebf \u0111\u1ed9 \u0103n u\u1ed1ng k\u00e9m dinh d\u01b0\u1ee1ng c\u00f3 th\u1ec3 l\u00e0m t\u0103ng nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 m\u1ed9t c\u00e1ch \u0111\u00e1ng k\u1ec3. Kh\u1ea9u ph\u1ea7n \u0103n nhi\u1ec1u ch\u1ea5t b\u00e9o v\u00e0 cholesterol c\u00f3 th\u1ec3 sinh m\u1ea3ng b\u00e1m l\u00e0m h\u1eb9p \u0111\u1ed9ng m\u1ea1ch. Vi\u1ec7c ti\u00eau th\u1ee5 nhi\u1ec1u mu\u1ed1i cu\u0303ng c\u00f3 th\u1ec3 g\u00f3p ph\u1ea7n l\u00e0m cao huy\u1ebft \u00e1p; \u0111\u1ed3ng th\u1eddi h\u1ea5p th\u1ee5 nhi\u1ec1u ca-lo cu\u0303ng c\u00f3 th\u1ec3 l\u00e0m cho c\u01a1 th\u1ec3 tr\u1edf n\u00ean b\u00e9o ph\u00ec. M\u1ed9t ch\u1ebf \u0111\u1ed9 dinh d\u01b0\u1ee1ng gi\u00e0u tr\u00e1i c\u00e2y, rau, ng\u0169 c\u1ed1c nguy\u00ean h\u1ea1t, v\u00e0 c\u00e1 c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m nguy c\u01a1 \u0111\u1ed9t qu\u1ef5.  C\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro kh\u00f4ng th\u1ec3 tr\u00e1nh kh\u1ecfi  M\u1ed9t s\u1ed1 nguy c\u01a1 g\u00e2y \u0111\u1ed9t qu\u1ef5 ngo\u00e0i t\u1ea7m ki\u1ec3m so\u00e1t c\u1ee7a b\u1ea1n, ch\u1eb3ng h\u1ea1n nh\u01b0 tu\u1ed5i t\u00e1c ho\u1eb7c c\u00f3 ti\u1ec1n s\u1eed gia \u0111\u00ecnh b\u1ecb \u0111\u1ed9t qu\u1ef5. Ngo\u00e0i ra, gi\u1edbi t\u00ednh cu\u0303ng \u0111\u00f3ng vai tr\u00f2 quan tr\u1ecdng, nam gi\u1edbi c\u00f3 nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 nhi\u1ec1u h\u01a1n. Tuy nhi\u00ean s\u1ed1 ca t\u1eed vong do \u0111\u1ed9t qu\u1ef5 nhi\u1ec1u h\u01a1n \u1edf n\u1eef. Nh\u00e2n t\u1ed1 quan tr\u1ecdng cu\u1ed1i cu\u0300ng l\u00e0 ch\u1ee7ng t\u1ed9c. Ng\u01b0\u1eddi M\u1ef9 g\u1ed1c Phi, th\u1ed5 d\u00e2n ch\u00e2u M\u1ef9, v\u00e0 ng\u01b0\u1eddi b\u1ea3n x\u1ee9 Alaska c\u00f3 nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 nhi\u1ec1u h\u01a1n so v\u1edbi ng\u01b0\u1eddi thu\u1ed9c c\u00e1c ch\u1ee7ng t\u1ed9c kh\u00e1c.  \u0110\u1ed9t qu\u1ef5: Ch\u1eefa tr\u1ecb kh\u1ea9n c\u1ea5p  \u0110\u1ed1i v\u1edbi ch\u1ee9ng \u0111\u1ed9t qu\u1ef5 do thi\u1ebfu m\u00e1u c\u1ee5c b\u1ed9 th\u00ec ph\u01b0\u01a1ng ph\u00e1p ch\u1eefa tr\u1ecb kh\u1ea9n c\u1ea5p l\u00e0 du\u0300ng thu\u1ed1c l\u00e0m l\u01b0u th\u00f4ng m\u00e1u b\u00ecnh th\u01b0\u1eddng tr\u1edf l\u1ea1i. Thu\u1ed1c ch\u1ed1ng huy\u1ebft kh\u1ed1i cu\u0303ng c\u00f3 t\u00e1c d\u1ee5ng cao trong vi\u1ec7c l\u00e0m tan m\u00e1u \u0111\u00f4ng v\u00e0 giu\u0301p gi\u1ea3m thi\u1ec3u t\u1ed5n th\u01b0\u01a1ng l\u00e2u d\u00e0i, nh\u01b0ng thu\u1ed1c n\u00e0y ph\u1ea3i \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng trong v\u00f2ng 3 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 khi m\u1edbi b\u1eaft \u0111\u1ea7u b\u1ed9c ph\u00e1t c\u00e1c tri\u1ec7u ch\u1ee9ng. \u0110\u1ed9t qu\u1ef5 xu\u1ea5t huy\u1ebft th\u01b0\u1eddng kh\u00f3 tr\u1ecb h\u01a1n. B\u00e1c s\u0129 th\u01b0\u1eddng ph\u1ea3i c\u1ed1 \u0111i\u1ec1u ho\u00e0 huy\u1ebft \u00e1p, l\u00e0m ng\u01b0ng xu\u1ea5t huy\u1ebft v\u00e0 phu\u0300 n\u00e3o.  \u0110\u1ed9t qu\u1ef5: T\u1ed5n th\u01b0\u01a1ng l\u00e2u d\u00e0i  \u0110\u1ed9t qu\u1ef5 c\u00f3 \u0111\u1ec3 l\u1ea1i t\u1ed5n th\u01b0\u01a1ng l\u00e2u d\u00e0i hay kh\u00f4ng tu\u1ef3 thu\u1ed9c v\u00e0o t\u00ednh ch\u1ea5t nghi\u00eam tr\u1ecdng v\u00e0 ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ec3 l\u00e0m \u1ed5n \u0111\u1ecbnh n\u00e3o nhanh ch\u00f3ng nh\u01b0 th\u1ebf n\u00e0o. Lo\u1ea1i th\u01b0\u01a1ng t\u1ed5n cu\u0303ng tu\u1ef3 thu\u1ed9c v\u00e0o vu\u0300ng n\u00e3o n\u01a1i m\u00e0 \u0111\u1ed9t qu\u1ef5 x\u1ea3y ra. C\u00e1c v\u1ea5n \u0111\u1ec1 th\u01b0\u1eddng th\u1ea5y sau khi b\u1ec7nh nh\u00e2n b\u1ecb \u0111\u1ed9t qu\u1ef5 l\u00e0 hi\u1ec7n t\u01b0\u1ee3ng ch\u00e2n ho\u1eb7c tay b\u1ecb t\u00ea c\u1ee9ng, kh\u00f3 \u0111i \u0111\u1ee9ng, kh\u00f3 nh\u00ecn th\u1ea5y r\u00f5, kh\u00f3 nu\u1ed1t v\u00e0 kh\u00f3 n\u00f3i chuy\u1ec7n cu\u0303ng nh\u01b0 kh\u00f3 hi\u1ec3u \u0111\u01b0\u1ee3c ng\u01b0\u1eddi kh\u00e1c n\u00f3i g\u00ec. Nh\u1eefng v\u1ea5n \u0111\u1ec1 n\u00e0y c\u00f3 th\u1ec3 s\u1ebd l\u00e0 m\u00e3i m\u00e3i, nh\u01b0ng nhi\u1ec1u ng\u01b0\u1eddi cu\u0303ng \u0111\u00e3 ph\u1ee5c h\u1ed3i l\u1ea1i \u0111\u01b0\u1ee3c h\u1ea7u h\u1ebft c\u00e1c kh\u1ea3 n\u0103ng c\u1ee7a m\u00ecnh.  Ph\u1ee5c h\u1ed3i sau \u0111\u1ed9t qu\u1ef5: Li\u1ec7u ph\u00e1p ng\u00f4n ng\u1eef  Ph\u1ee5c h\u1ed3i l\u00e0 giai \u0111o\u1ea1n quan tr\u1ecdng trong qu\u00e1 tr\u00ecnh b\u00ecnh ph\u1ee5c sau \u0111\u1ed9t qu\u1ef5. N\u00f3 giu\u0301p b\u1ec7nh nh\u00e2n ph\u1ee5c h\u1ed3i l\u1ea1i nh\u1eefng k\u0129 n\u0103ng b\u1ecb m\u1ea5t v\u00e0 bi\u1ebft c\u00e1ch bu\u0300 \u0111\u1eafp th\u01b0\u01a1ng t\u1eadt c\u1ee7a m\u00ecnh. M\u1ee5c \u0111\u00edch c\u1ee7a ph\u1ee5c h\u1ed3i l\u00e0 giu\u0301p kh\u00f4i ph\u1ee5c l\u1ea1i t\u00ednh \u0111\u1ed9c l\u1eadp \u1edf b\u1ec7nh nh\u00e2n c\u00e0ng nhi\u1ec1u c\u00e0ng t\u1ed1t. \u0110\u1ed1i v\u1edbi ng\u01b0\u1eddi kh\u00f3 n\u00f3i chuy\u1ec7n th\u00ec li\u1ec7u ph\u00e1p ng\u00f4n ng\u1eef l\u00e0 quan tr\u1ecdng. Nh\u00e0 \u00e2m ng\u1eef tr\u1ecb li\u1ec7u cu\u0303ng c\u00f3 th\u1ec3 giu\u0301p b\u1ec7nh nh\u00e2n gi\u1ea3i quy\u1ebft v\u1ea5n \u0111\u1ec1 kh\u00f3 nu\u1ed1t.  Ph\u1ee5c h\u1ed3i sau \u0111\u1ed9t qu\u1ef5: V\u1eadt l\u00fd tr\u1ecb li\u1ec7u  Y\u1ebfu c\u01a1 cu\u0303ng nh\u01b0 c\u00e1c v\u1ea5n \u0111\u1ec1 th\u0103ng b\u1eb1ng l\u00e0 nh\u1eefng hi\u1ec7n t\u01b0\u1ee3ng th\u01b0\u1eddng th\u1ea5y sau \u0111\u1ed9t qu\u1ef5. \u0110i\u1ec1u n\u00e0y l\u00e0m c\u1ea3n tr\u1edf vi\u1ec7c \u0111i \u0111\u1ee9ng v\u00e0 c\u00e1c ho\u1ea1t \u0111\u1ed9ng th\u01b0\u1eddng nh\u1eadt kh\u00e1c. v\u1eadt l\u00fd tr\u1ecb li\u1ec7u l\u00e0 ph\u01b0\u01a1ng ph\u00e1p hi\u1ec7u qu\u1ea3 nh\u1eb1m ph\u1ee5c h\u1ed3i s\u1ee9c m\u1ea1nh, th\u0103ng b\u1eb1ng v\u00e0 k\u0129 n\u0103ng ph\u1ed1i h\u01a1p. \u0110\u1ed1i v\u1edbi nh\u1eefng k\u0129 n\u0103ng ho\u1ea1t \u0111\u1ed9ng c\u01a1 ch\u00ednh x\u00e1c, nh\u01b0 l\u00e0 s\u1eed d\u1ee5ng n\u0129a dao, vi\u1ebft, v\u00e0 c\u00e0i khuy \u00e1o, th\u00ec lao \u0111\u1ed9ng li\u1ec7u ph\u00e1p (ch\u1eefa b\u1ec7nh b\u1eb1ng lao \u0111\u1ed9ng) c\u00f3 th\u1ec3 giu\u0301p \u00edch \u0111\u01b0\u1ee3c.  Ph\u1ee5c h\u1ed3i sau \u0111\u1ed9t qu\u1ef5: Li\u1ec7u ph\u00e1p tr\u00f2 chuy\u1ec7n  Ng\u01b0\u1eddi s\u1ed1ng s\u00f3t sau c\u01a1n \u0111\u1ed9t qu\u1ef5 v\u00e0 ng\u01b0\u1eddi th\u00e2n c\u1ee7a h\u1ecd th\u01b0\u1eddng tr\u1ea3i qua r\u1ea5t nhi\u1ec1u c\u1ea3m xu\u0301c d\u1eef d\u1ed9i, ch\u1eb3ng h\u1ea1n nh\u01b0 c\u1ea3m gi\u00e1c s\u1ee3 h\u00e3i, t\u1ee9c gi\u1eadn, lo \u00e2u, v\u00e0 \u0111au bu\u1ed3n.\u00a0 Nh\u00e0 t\u00e2m l\u00fd ho\u1eb7c nh\u00e0 c\u1ed1 v\u1ea5n s\u1ee9c kh\u1ecfe t\u00e2m th\u1ea7n c\u00f3 th\u1ec3 h\u01b0\u1edbng d\u1eabn cho b\u1ea1n nhi\u1ec1u bi\u1ec7n ph\u00e1p kh\u1eafc ph\u1ee5c c\u00e1c c\u1ea3m xu\u0301c \u0111\u00f3. Nh\u00e0 tr\u1ecb li\u1ec7u c\u0169ng c\u00f3 th\u1ec3 quan s\u00e1t c\u00e1c d\u1ea5u hi\u1ec7u c\u1ee7a ch\u1ee9ng tr\u1ea7m c\u1ea3m th\u01b0\u1eddng x\u1ea3y ra \u1edf ng\u01b0\u1eddi \u0111ang ph\u1ee5c h\u1ed3i sau \u0111\u1ed9t qu\u1ef5.  Ph\u00f2ng tr\u00e1nh \u0111\u1ed9t qu\u1ef5 b\u1eb1ng l\u1ed1i s\u1ed1ng c\u00e1 nh\u00e2n Ng\u01b0\u1eddi \u0111\u00e3 t\u1eebng b\u1ecb \u0111\u1ed9t qu\u1ef5 ho\u1eb7c b\u1ecb \u0111\u1ed9t qu\u1ef5 tho\u00e1ng qua c\u00f3 th\u1ec3 th\u1ef1c hi\u1ec7n c\u00e1c bi\u1ec7n ph\u00e1p d\u01b0\u1edbi \u0111\u00e2y \u0111\u1ec3 ng\u0103n ng\u1eeba t\u00e1i ph\u00e1t:  * B\u1ecf thu\u1ed1c l\u00e1. * T\u1eadp th\u1ec3 d\u1ee5c v\u00e0 duy tr\u00ec tr\u1ecdng l\u01b0\u1ee3ng c\u01a1 th\u1ec3 kh\u1ecfe m\u1ea1nh. * H\u1ea1n ch\u1ebf s\u1eed d\u1ee5ng r\u01b0\u1ee3u bia v\u00e0 l\u01b0\u1ee3ng mu\u1ed1i h\u1ea5p thu. * C\u00f3 ch\u1ebf \u0111\u1ed9 dinh d\u01b0\u1ee1ng kh\u1ecfe m\u1ea1nh v\u1edbi nhi\u1ec1u rau, c\u00e1, v\u00e0 ng\u0169 c\u1ed1c nguy\u00ean h\u1ea1t.  Ph\u00f2ng tr\u00e1nh \u0111\u1ed9t qu\u1ef5 b\u1eb1ng thu\u1ed1c \u0110\u1ed1i v\u1edbi ng\u01b0\u1eddi c\u00f3 nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 cao, b\u00e1c s\u0129 th\u01b0\u1eddng ch\u1ec9 \u0111\u1ecbnh nhi\u1ec1u lo\u1ea1i thu\u1ed1c l\u00e0m gi\u1ea3m nguy c\u01a1 n\u00e0y. Nhi\u1ec1u thu\u1ed1c ch\u1ed1ng huy\u1ebft kh\u1ed1i (kh\u00e1ng ti\u1ec3u c\u1ea7u), bao g\u1ed3m aspirin, c\u00f3 t\u00e1c d\u1ee5ng l\u00e0m cho ti\u1ec3u huy\u1ebft c\u1ea7u kh\u00f4ng b\u1ecb k\u1ebft d\u00ednh \u0111\u00f4ng t\u1ee5 l\u1ea1i th\u00e0nh c\u1ee5c trong m\u00e1u. Thu\u1ed1c ch\u1ed1ng \u0111\u00f4ng m\u00e1u, ch\u1eb3ng h\u1ea1n nh\u01b0 warfarin, c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng nh\u1eb1m \u0111\u1ec1 ph\u00f2ng \u0111\u1ed9t qu\u1ef5 \u1edf m\u1ed9t s\u1ed1 b\u1ec7nh nh\u00e2n. Cu\u1ed1i cu\u0300ng l\u00e0 n\u1ebfu b\u1ea1n b\u1ecb cao huy\u1ebft \u00e1p th\u00ec b\u00e1c s\u0129 s\u1ebd k\u00ea toa cho b\u1ea1n \u0111\u1ec3 l\u00e0m gi\u1ea3m huy\u1ebft \u00e1p.  Ph\u00f2ng tr\u00e1nh \u0111\u1ed9t qu\u1ef5 b\u1eb1ng gi\u1ea3i ph\u1eabu Trong m\u1ed9t s\u1ed1 tr\u01b0\u1eddng h\u1ee3p, b\u1ec7nh nh\u00e2n \u0111\u1ed9t qu\u1ef5 do b\u1ecb h\u1eb9p \u0111\u1ed9ng m\u1ea1ch c\u1ea3nh \u2013 c\u00e1c m\u1ea1ch m\u00e1u \u0111i l\u00ean 2 b\u00ean c\u1ed5 \u0111\u1ec3 v\u1eadn chuy\u1ec3n m\u00e1u \u0111\u1ebfn n\u00e3o. Ng\u01b0\u1eddi \u0111\u00e3 t\u1eebng b\u1ecb \u0111\u1ed9t qu\u1ef5 nh\u1eb9 ho\u1eb7c \u0111\u1ed9t qu\u1ef5 tho\u00e1ng qua do h\u1eb9p \u0111\u1ed9ng m\u1ea1ch c\u1ea3nh c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ph\u1eabu thu\u1eadt \u0111\u1ec3 c\u1eaft b\u1ecf vi\u00eam \u00e1o \u0111\u1ed9ng m\u1ea1ch c\u1ea3nh. Th\u1ee7 thu\u1eadt n\u00e0y l\u1ea5y \u0111i m\u1ea3ng b\u00e1m kh\u1ecfi ni\u00eam m\u1ea1c c\u1ee7a c\u00e1c \u0111\u1ed9ng m\u1ea1ch c\u1ea3nh v\u00e0 c\u00f3 th\u1ec3 ph\u00f2ng tr\u00e1nh c\u00e1c c\u01a1n \u0111\u1ed9t qu\u1ef5 kh\u00e1c c\u00f3 th\u1ec3 x\u1ea3y ra.  Ph\u00f2ng tr\u00e1nh \u0111\u1ed9t qu\u1ef5 b\u1eb1ng kh\u00ed c\u1ea7u v\u00e0 \u1ed1ng Stent B\u00e1c s\u0129 cu\u0303ng c\u00f3 th\u1ec3 \u0111i\u1ec1u tr\u1ecb ch\u1ee9ng ngh\u1ebdn \u0111\u1ed9ng m\u1ea1ch c\u1ea3nh m\u00e0 kh\u00f4ng c\u1ea7n \u0111\u1ebfn bi\u1ec7n ph\u00e1p ph\u1eabu thu\u1eadt trong m\u1ed9t s\u1ed1 tr\u01b0\u1eddng h\u1ee3p. Th\u1ee7 thu\u1eadt n\u00e0y \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 gi\u1ea3i ph\u1eabu th\u00f4ng \u0111\u1ed9ng m\u1ea1ch b\u1ecb t\u1eafc ho\u1eb7c h\u1eb9p, b\u00e1c s\u0129 t\u1ea1m th\u1eddi \u0111\u1eb7t m\u1ed9t \u1ed1ng th\u00f4ng v\u00e0o \u0111\u1ed9ng m\u1ea1ch v\u00e0 th\u1ed5i ph\u1ed3ng kh\u00ed c\u1ea7u nh\u1ecf \u0111\u1ec3 l\u00e0m n\u1edf to \u0111\u1ed9ng m\u1ea1ch \u0111\u00e3 b\u1ecb m\u1ea3ng b\u00e1m l\u00e0m h\u1eb9p. \u0110\u1ed3ng th\u1eddi b\u00e1c s\u0129 cu\u0303ng \u0111\u1eb7t v\u00e0o m\u1ed9t \u1ed1ng kim lo\u1ea1i, g\u1ecdi l\u00e0 \u1ed1ng stent \u0111\u1ec3 l\u00e0m r\u1ed9ng \u0111\u1ed9ng m\u1ea1ch.\u00a0  Cu\u1ed9c s\u1ed1ng sau khi b\u1ecb \u0111\u1ed9t qu\u1ef5  H\u01a1n m\u1ed9t n\u1eeda b\u1ec7nh nh\u00e2n b\u1ecb \u0111\u1ed9t qu\u1ef5 c\u00f3 th\u1ec3 ph\u1ee5c h\u1ed3i kh\u1ea3 n\u0103ng t\u1ef1 ch\u0103m s\u00f3c b\u1ea3n th\u00e2n. N\u1ebfu \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng thu\u1ed1c ch\u1ed1ng huy\u1ebft kh\u1ed1i s\u1edbm k\u1ecbp th\u1eddi th\u00ec h\u1ecd c\u00f3 th\u1ec3 h\u1ed3i ph\u1ee5c m\u1ed9t c\u00e1ch tr\u1ecdn v\u1eb9n. B\u00ean c\u1ea1nh \u0111\u00f3 ng\u01b0\u1eddi b\u1ecb khuy\u1ebft t\u1eadt cu\u0303ng th\u01b0\u1eddng c\u00f3 th\u1ec3 bi\u1ebft c\u00e1ch ho\u1ea1t \u0111\u1ed9ng \u0111\u1ed9c l\u1eadp nh\u1edd v\u00e0o li\u1ec7u ph\u00e1p. Trong khi nguy c\u01a1 \u0111\u1ed9t qu\u1ef5 l\u1ea7n th\u1ee9 hai cao h\u01a1n l\u1ea7n \u0111\u1ea7u th\u00ec nguy c\u01a1 n\u00e0y s\u1ebd c\u00f3 th\u1ec3 gi\u1ea3m d\u1ea7n theo th\u1eddi gian."
        },
        {
            "en": "Your child\u2019s immunization        At birth, infants have protection against certain diseases because antibodies have passed through the placenta from the mother to the unborn child. After birth, breastfed babies get the continued benefits of additional antibodies in breast milk. But in both cases, the protection is temporary. Immunization (vaccination) is a way of creating immunity to certain diseases by using small amounts of a killed or weakened microorganism that causes the particular disease. Microorganisms can be viruses, such as the measles virus, or they can be bacteria, such as pneumococcus. Vaccines stimulate the immune system to react as if there were a real infection \u2014 it fends off the \"infection\" and remembers the organism so that it can fight it quickly should it enter the body later. Some parents may hesitate to have their kids vaccinated because they're worried that the children will have serious reactions or may get the illness the vaccine is supposed to prevent. Because the components of vaccines are weakened or killed \u2014 and in some cases, only parts of the microorganism are used \u2014 they're unlikely to cause any serious illness. Some vaccines may cause mild reactions, such as soreness where the shot was given or fever, but serious reactions are rare. The risks of vaccinations are small compared with the health risks associated with the diseases they're intended to prevent. The following vaccinations and schedules are recommended by the American Academy of Pediatrics (AAP). Please note that some variations are acceptable and that changes in recommendations frequently occur as new vaccines are developed. The AAP recommends that children get combination vaccines (rather than single vaccines) whenever possible. Many vaccines are offered in combination to help reduce the number of shots a child receives. Your doctor will determine the best vaccinations and schedule for your child. Recommended vaccinations: Hepatitis B Hepatitis B virus (HBV) affects the liver. Those who are infected can become lifelong carriers of the virus and may develop long-term problems such as cirrhosis (liver disease) or cancer of the liver. Immunization schedule Hepatitis B vaccine usually is given as a series of three injections. The first shot is often given to infants shortly after birth. If the mother of a newborn carries the hepatitis B virus in her blood, the infant needs to receive the first shot within 12 hours after birth, along with another shot (HBIG) to immediately provide protection against the virus. If a newborn's mother shows no evidence of HBV in her blood, the infant may receive the hepatitis B vaccine any time prior to leaving the hospital. It may also be delayed until the 1- or 2- month visit to your doctor. If the first dose is given shortly after birth, the second shot is given at 1 to 2 months and the third at 6 to 18 months. For infants who don't receive the first shot until 1 to 2 months, the second shot is given at 3 to 4 months and the third at 6 to 18 months. In either case, the second and third shots are usually given in conjunction with other routine childhood immunizations. Why the vaccine is recommended The hepatitis B vaccine usually creates long-term immunity. Infants who receive the HBV series should be protected from hepatitis B infection not only throughout their childhood but also into the adult years. Eliminating the risk of infection also decreases risk for cirrhosis of the liver, chronic liver disease, and liver cancer. Young adults and adolescents should also receive the vaccine if they did not as infants. Possible risks There is a very small chance of an allergic reaction with any vaccine. Serious problems associated with receiving the HBV vaccine are rare. Problems that do occur tend to be minor, such as fever or redness or tenderness at the injection site. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if a severe allergic reaction (called anaphylaxis) occurred after a previous injection of the HBV vaccine Caring for your child after immunization The vaccine may cause mild fever, and soreness and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Very young infants should not be given either medication, but for older infants or children, check with the doctor about the appropriate medication and dose. When to call the doctor * if you're not sure of the recommended schedule for the hepatitis B vaccine  * if you have concerns about your own HBV carrier state  * if serious adverse symptom appear after your child has received an HBV injection  Pneumococcal Vaccine (PCV) The pneumococcal conjugate vaccine (PCV) protects against pneumococcal infections. The bacterium is a leading cause of serious infections, including pneumonia, blood infections, and bacterial meningitis. Children under 2 years old, adults over 65 years old, and people with certain medical conditions are most susceptible to serious pneumococcal infections. The pneumococcus bacterium is spread through person-to-person contact. The vaccine not only prevents the infection in children who receive it, it also helps stop its spread. Immunization schedule PCV immunizations are given as a series of four injections starting at 2 months of age and following at 4 months, 6 months, and 12 to 15 months. Kids who miss the first dose or may have missed subsequent doses due to vaccine shortage should still receive the vaccine, and your doctor can give you a modified schedule for immunization. Why the vaccine is recommended The most serious infections affect children younger than 2 years old, and the vaccine will protect them when they're at greatest risk. PCV also is recommended for kids between 2 and 5 years of age who are at high risk for serious pneumococcal infections because they have medical problems such as: * sickle cell anemia  * a damaged spleen or no spleen  * HIV/AIDS  * cochlear implants  * a disease that affects the immune system, such as diabetes or cancer  * receiving medications that affect the immune system, such as steroids or chemotherapy  * chronic heart or lung disease  In addition, these high-risk children may also receive the pneumococcal polysaccharide vaccine (PPV) in addition to the PCV when they're older than 24 months. Possible risks Children who receive the PCV vaccine may have redness, tenderness, or swelling where the shot was given. A child may also have a fever after receiving the shot. There is a very small chance of an allergic reaction with any vaccine.  When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has had a severe allergic reaction to a previous dose of the vaccine  Caring for your child after immunization The vaccine may cause mild fever, and soreness and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. When to call the doctor * if your child missed a dose in the series  * if a severe allergic reaction or high fever occurs after immunization DTaP The DTaP vaccine protects against: * diphtheria \u2014 a serious infection of the throat that can block the airway and cause severe breathing difficulty  * tetanus \u2014 a nerve disease, which can occur at any age, caused by toxin-producing bacteria contaminating a wound  * pertussis (whooping cough) \u2014 a respiratory illness with cold symptoms that progress to severe coughing (the \"whooping\" sound occurs when the child breathes in deeply after a severe coughing bout); serious complications of pertussis can occur in children under 1 year of age, and those under 6 months old are especially susceptible. Teens and adults with a persistent cough may not realize they have pertussis, and may pass it to vulnerable infants.  Immunization schedule DTaP immunizations are given as a series of five injections and are usually administered at ages 2 months, 4 months, 6 months, 15 to 18 months, and 4 to 6 years. After the initial series of immunizations, a vaccine called Tdap (the booster shot) should be given at ages 11 to 12, or to older teens and adults who haven't yet received a booster with pertussis coverage. Then, Td (tetanus and diphtheria) boosters are recommended every 10 years.  Why the vaccine is recommended Use of the DTaP vaccine has virtually eliminated diphtheria and tetanus in childhood and has markedly reduced the number of pertussis cases. Possible risks The vaccine frequently causes mild side effects: fever, mild crankiness, tiredness, loss of appetite, and tenderness, redness, or swelling in the area where the shot was given. Rarely, seizures or allergic reactions can occur following DTaP. Most of these side effects result from the pertussis component of the vaccine. Severe complications caused by DTaP immunization are rare. Most kids have little or no problem. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has an uncontrolled seizure disorder or certain neurologic diseases or seems not to be developing normally \u2014 the pertussis component of the vaccine may not be given, and your child may receive a DT (diphtheria and tetanus) vaccine instead  If your child experienced any of the following after an earlier DTaP, consult with your doctor before your child receives another injection of the vaccine: * seizures within 7 days after injection  * worsening of seizures  * an allergic reaction after receiving the vaccine, such as mouth, throat, or facial swelling  * difficulty breathing  * temperature of 105\u00b0 Fahrenheit (40.5\u00b0 Celsius) or higher during the first 2 days after injection  * shock or collapse during the first 2 days after injection  * persistent, uncontrolled crying that lasts for more than 3 hours during the first 2 days after injection  Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. A warm, damp cloth or a heating pad also may help reduce soreness. Moving or using the limb that has received the injection often reduces the soreness. When to call the doctor * if you aren't sure whether the vaccine should be postponed or avoided. Children who have had certain problems with the DTaP vaccine usually can safely receive the DT vaccine.  * if complications or severe symptoms develop after immunization, including seizures, fever above 105\u00b0 Fahrenheit (40.5\u00b0 Celsius), difficulty breathing or other signs of allergy, shock or collapse, or uncontrolled crying for more than 3 hours  Hib Haemophilus influenzae type b bacteria were the leading cause of meningitis in children under 5 years until the Hib vaccine became available. Immunization schedule The Hib vaccine is given by injection at ages 2 months, 4 months, and 6 months (however, some of the Hib vaccines do not require a dose at 6 months). A booster dose is given at 12 to 15 months. Why the vaccine is recommended The vaccine provides long-term protection from Haemophilus influenzae type b. Those immunized have protection against Hib meningitis, pneumonia, pericarditis (an infection of the membrane covering the heart), and infections of the blood, bones, and joints caused by the bacteria. Possible risks Minor problems, such as redness, swelling, or tenderness where the shot was given, may occur. There is a very small chance of an allergic reaction with any vaccine. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if severe allergic reaction occurs after an injection of the Hib vaccine, further Hib immunizations may not be given to your child  Caring for your child after immunization The vaccine may cause mild soreness and redness in the area where the shot was given. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. When to call the doctor * if you aren't sure whether the vaccine should be postponed or avoided  * if serious adverse reactions appear after the Hib injection  IPV Polio is a viral infection that can result in permanent paralysis. Immunization schedule The inactivated poliovirus vaccine (IPV) is usually given at ages 2 months, 4 months, 6 to 18 months, and 4 to 6 years. Until recently, the oral poliovirus vaccine (OPV) was given in the United States. Updated recommendations by the Advisory Committee on Immunization Practices now call for IPV injections. This change eliminates the previous small risk of developing polio after receiving the live oral polio vaccine. Why the vaccine is recommended The vaccine offers protection against polio, which can cause paralysis and death. Possible risks Side effects include fever and redness or soreness at the site of injection. There is a very small chance of an allergic reaction with any vaccine. When to delay or avoid immunization * IPV should not be given to kids with severe allergy to neomycin, streptomycin, or polymyxin B.  * IPV should not be given to kids who had a severe allergic reaction to a previous IPV shot.  Caring for your child after immunization IPV may cause mild fever, and soreness and redness at the site of the injection for several days. Depending on the age of your child, pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. When to call the doctor * if you aren't sure whether the vaccine should be postponed or avoided  * if severe adverse reactions occur after the immunization Influenza Influenza, or \"the flu,\" is a highly contagious viral infection of the respiratory tract. Immunization schedule Beginning in the 2010-2011 flu season, the seasonal flu vaccine protects against H1N1 flu, as well as other flu viruses. The Centers for Disease Control and Prevention (CDC) recommends the flu vaccine for all people age 6 months and older. Certain people are at higher risk of complications from the flu. They include: * pregnant women  * children younger than age 5, especially those younger than 2  * people age 65 and older  * people of any age who have chronic health conditions  Infants younger than 6 months are too young to receive the vaccine, but all other high risk persons should be vaccinated. Health care workers, caregivers, and close contacts of at-risk persons (including those who care for infants younger than 6 months) should also get the flu vaccine. In the past, there have been times when there were vaccine shortages and delays. So talk with your doctor about availability. For kids younger than 9 who are getting the seasonal influenza vaccine for the first time or did not get the H1N1 vaccine during the 2009-2010 flu season, it's given in two separate shots a month apart. It can take about 2 weeks after the shot is given for the body to build up protection against the flu. A non-shot option called the nasal mist vaccine came on the market in 2003 for the seasonal flu and is now approved for use in healthy 2- to 49-year-olds. The nasal mist contains live but weakened virus that will not cause the flu. However, the vaccine isn't recommended for kids with certain medical conditions or pregnant women. Talk to your doctor about which vaccine is right for your child. Why the vaccine is recommended The flu vaccine reduces a person's chances of catching the flu by up to 80% during the season. Getting the shot before the flu season is in full force gives the body a chance to build up immunity to, or protection from, the virus. The shot usually becomes available between September and mid-November. Although you can get a flu shot well into flu season, it's best to try to get it earlier rather than later. However, later in the flu season, it's still a good idea to get protection. Even if you or your child got the seasonal flu vaccine last year, that won't protect you from getting the seasonal flu this year, because the protection wears off and flu viruses constantly change. That's why the vaccine is updated each year to include the most current strains of the virus. A good example of how flu viruses change (and sometimes develop new strains) was the outbreak of the H1N1 flu in 2009. This flu strain was not included in the 2009-2010 seasonal flu vaccine, so a separate H1N1 flu vaccine was developed. Since then, the H1N1 flu shot has been incorporated into the seasonal flu shot.  Possible risks Usually given as an injection in the upper arm, the flu shot contains killed flu viruses that will not cause someone to get the flu, but will cause the body to make antibodies to fight off a live flu virus if it does enter the body.  Some of the most common side effects from the flu shot are soreness, redness, or swelling at the site of the injection. A low-grade fever and aches are also possible. Because the nasal spray flu vaccine is made from live viruses, it may cause mild flu-like symptoms, including runny nose, headache, vomiting, muscle aches, and fever. Very rarely, the flu vaccine can cause serious side effects such as a severe allergic reaction. When to delay or avoid immunization People who should not get the seasonal flu shot include: * infants under 6 months old  * anyone who's severely allergic to eggs and egg products. Tell the doctor if your child is allergic before he or she gets a flu shot. * anyone who's ever had a severe reaction to a flu vaccination  * anyone who's had Guillain-Barr\u00e9 syndrome (GBS, a rare medical condition that affects the nerves)  * anyone with a severe illness Caring for your child after immunization Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. Some doctors recommend a dose just before the immunization. A warm, damp cloth or a heating pad also may help minimize soreness. Moving or using the limb that has received the injection often reduces the soreness as well. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are serious problems after the immunization, such as an allergic reaction, high fever, or other concern  MMR (measles, mumps, rubella) The MMR vaccine protects against measles, mumps, and rubella (German measles). MMR vaccinations are given by injection in two doses. The first is administered at age 12 to 15 months; the second generally is given at age 4 to 6 years. Why the vaccine is recommended Measles, mumps, and rubella are infections that can lead to significant illness. More than 95% of children receiving MMR will be protected from the three diseases throughout their lives. Possible risks Serious problems such as allergic reactions are rare. Potential mild to moderate adverse effects include rash, fever, swollen cheeks, febrile seizures, and mild joint pain. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has an allergy to gelatin or to the antibiotic neomycin, check with your doctor about immunization  * if your child had a severe allergic reaction to a previous dose of MMR vaccine  * if your child has recently received gamma globulin or a blood transfusion, check with your doctor about immunization  * if your child has a medical problem that affects the immune system, such as cancer  * if your child is taking prednisone, steroids, or other immunosuppressive drugs  * if your child is undergoing chemotherapy or radiation therapy  * if your child has ever had a low <em>platelet</em> count, check with your doctor about immunization  * pregnant women should wait until after delivery for the vaccine  Caring for your child after immunization If a rash develops without other symptoms, no treatment is necessary and it should resolve within several days. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and find out the appropriate dose. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  Varicella (chickenpox) The varicella vaccine protects against chickenpox (varicella), a common and very contagious childhood viral illness. Immunization schedule The varicella vaccine is given by injection between the ages of 12 and 15 months, followed by a booster shot at 4 to 6 years of age for further protection. Older kids under the age of 13 years who have not had chickenpox may also receive the vaccine, with the two doses given at least 3 months apart. Kids 13 years or older who have not had either chickenpox or the vaccine need two vaccine doses at least 1 month apart. Why the vaccine is recommended The varicella vaccine prevents severe illness in almost all children who are immunized. It's up to 85% effective in preventing mild illness. Vaccinated kids who do get chickenpox generally have a mild case. Possible risks Serious reactions such as allergic reactions are extremely rare. Possible mild effects are tenderness and redness where the shot was given, fever, fatigue, and a varicella-like illness. A rash can occur up to 1 month after the injection. It may last for several days but will disappear on its own without treatment. There is a very small risk of febrile seizures after vaccination. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your child has an allergy to gelatin or to the antibiotic neomycin  * if your child had a severe allergic reaction to a previous dose of varicella vaccine  * if your child has recently received gamma globulin or a blood transfusion, talk to your doctor about immunization  * if your child has a disorder that affects the immune system, such as cancer; is taking prednisone, steroids, or other immunosuppressive drugs; or is undergoing chemotherapy or radiation therapy  * pregnant women should wait until after delivery for vaccination  Caring for your child after immunization Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and find out the appropriate dose. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization MCV4 The meningitis vaccine protects against meningococcal disease, a serious bacterial infection that can lead to bacterial meningitis. The vaccine is recommended for kids at age 11 or 12 years, at ages 13 to 18 years if not previously vaccinated, and older teens who are entering college and will be living in a dormitory setting, and those entering the military. It is also recommended for children between the ages of 2 and 10 with certain high risk medical problems. When medical problems continue, these kids also need a follow-up booster dose a few years later, depending on the age at which the first dose was given. Why the vaccine is recommended Bacterial meningitis, an inflammation of the membrane that protects the brain and spinal cord, is a rare but highly contagious disease that can spread rapidly among kids who are in close quarters. It can be life-threatening if not promptly treated. Possible risks Some of the most common side effects are swelling, redness, and pain at the site of the injection, along with headache, fever, or fatigue. Severe problems, such as allergic reactions, are rare. When to delay or avoid immunization * if your child has had allergic reactions to the DTaP vaccine or to latex  * if your child has a history of Guillain-Barr\u00e9 syndrome, a disease of the nervous system which causes progressive weakness  * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. A warm, damp cloth or a heating pad also may help reduce soreness. Moving or using the limb that has received the injection often reduces the soreness. When to Call the Doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization Hepatitis A The hepatitis A virus (HAV) causes fever, nausea, vomiting, and jaundice, and can lead to community-wide epidemics. Childcare centers are a common site of outbreaks. The vaccine is recommended for children 12 to 23 months old, followed by a second dose 6 months later. Although in the past the vaccine was recommended for older kids and adults who were at high risk for the disease (such as those who lived in or traveled to locations with high rates of HAV), the vaccine is now recommended for anyone who desires immunity to the disease. Why the vaccine is recommended Vaccination against HAV can help stop epidemics from developing in the community, in addition to protecting the individual child. Some infected children do not have any symptoms, and can spread the virus to others. The more young children who are vaccinated against HAV, the more limited the spread of disease will be in a community. Possible risks Side effects are usually mild fever, and tenderness, swelling, and redness at the site of the injection. Allergic reactions to the vaccine are rare. When to delay or avoid immunization * if your child is currently sick, although simple colds or other minor illnesses should not prevent immunization * if your child had an allergic reaction to the first dose of hepatitis A vaccine  Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  Rotavirus Rotavirus is a common virus that causes diarrhea, especially in infants and young children. Childcare centers are a common site of outbreaks. The vaccine, which is a liquid given by mouth, is recommended at ages 2 and 4 months, as well as a dose at 6 months depending on the brand vaccine used. Why the vaccine is recommended Rotavirus can cause dehydration secondary to large amounts of diarrhea, and can result in children requiring hospitalization. Vaccination against rotavirus can help stop spread in the community, in addition to protecting the individual child. Possible risks Side effects can include diarrhea and vomiting, in addition to fever. When to delay or avoid immunization * if your child is currently sick, although simple colds should not prevent immunization  * if your child had an allergic reaction to a previous dose of the vaccine  * let the doctor know if your child has an allergy to latex * if your child has an abnormality of the digestive system or a gastrointestinal disease, talk to your doctor about immunization  * if your child has a history of intussusception, a type of serious bowel blockage, talk to your doctor about immunization  * if your child has recently received gamma globulin or a blood transfusion  * if your child has immune system problems from a disease such as cancer; is taking steroids or other immunosuppressive drugs; or is undergoing chemotherapy or radiation therapy  Caring for your child after immunization Depending on the age of your child, fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and to find out the appropriate dose. If vomiting or diarrhea occur, make sure to give your child frequent amounts of fluid and watch for signs of dehydration, such as less urine than usual. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  HPV Human papillomavirus (HPV) is a sexually transmitted disease (STD) that causes genital warts and changes in the cervix that can result in cervical cancer. The vaccine is given as a series of three shots over a 6-month period and is recommended for girls 11 or 12 years old, as well as for older girls who are unvaccinated. The vaccine can also be given to boys ages 9 through 18 years, to prevent the development of genital warts.  Why the vaccine is recommended Because HPV can cause serious problems such as genital warts and cervical cancer, a vaccine is an important step in preventing infection and protecting against the spread of HPV. It works best when given before a girl becomes sexually active. Possible risks Side effects are usually mild fever and tenderness, swelling, and redness at the site of the injection. Dizziness, fainting, nausea, and vomiting may also occur after the shot. Allergic reactions to the vaccine occur rarely. When to delay or avoid immunization * if your daughter is currently sick, although simple colds or other minor illnesses should not prevent immunization  * if your daughter had an allergic reaction to the first dose of HPV vaccine  * if your daughter has had a severe allergic reaction to yeast  * if your daughter is pregnant  * if your daughter has a bleeding disorder (discuss with your hematologist)  Caring for your child after immunization Your child may experience fever, soreness, and some swelling and redness in the area where the shot was given. Pain and fever may be treated with acetaminophen or ibuprofen. Check with your doctor to see if you can give either medication, and find out the appropriate dose. When to call the doctor * if you aren't sure if the vaccine should be postponed or avoided  * if there are problems after the immunization  Immunization schedule This immunization schedule is a handy reference to help you keep track of which vaccines your child needs to receive and when. Types of vaccines Some types of vaccines are: 1. Attenuated (weakened) live viruses are used in some vaccines such as in the measles, mumps, and rubella (MMR) vaccine.  2. Killed (inactivated) viruses or bacteria are used in some vaccines, such as in IPV.  3. Toxoid vaccines contain an inactivated toxin produced by the bacterium. For example, the diphtheria and tetanus vaccines are toxoid vaccines.  4. Conjugate vaccines (such as Hib) contain parts of bacteria combined with proteins.  Immunizations for travel Specific information about which immunizations are required by travelers to each country worldwide is available directly from the Centers for Disease Control and Prevention (CDC). Ask your doctor for more information. Depending on the type and length of travel, some vaccines may be recommended. Most immunizations should be given at least 1 month before travel. Take your child's immunization records with you when you travel internationally. Helping kids through vaccine injections Sometimes it's hard to tell who dreads immunizations more \u2014 parents or kids. Here are some tips to help make the procedure easier for everyone: * Tell older kids what's going to happen and that the shot helps to keep them healthy.  * Tell younger kids that it's OK to cry, but also encourage them to be brave. * Try to be calm yourself. Your child can pick up on your concerns.  * Distraction at the moment of the injection is helpful. Try having kids count, sing a song with you, or look away (perhaps at a picture on the wall). You may want to have a joke or funny comment ready.  * Offer praise after the injection is over.  * Plan something fun for after the appointment. A trip to the park or playground can make the overall immunization experience less unpleasant.  As uneasy as getting vaccinated may make both you and your child, remember that immunizations are one of the best means of protection against contagious diseases.",
            "vi": "Ch\u1ee7ng ng\u1eeba cho con c\u1ee7a b\u1ea1n     Lu\u0301c m\u1edbi sinh, nh\u1edd kh\u00e1ng th\u1ec3 truy\u1ec1n t\u1eeb m\u1eb9 \u0111\u1ebfn thai nhi qua nhau thai n\u00ean tr\u1ebb c\u00f3 th\u1ec3 tr\u00e1nh kh\u1ecfi m\u1ed9t s\u1ed1 b\u1ec7nh n\u00e0o \u0111\u00f3. Sau khi ra \u0111\u1eddi, tr\u1ebb bu\u0301 m\u1eb9 v\u1eabn \u0111\u01b0\u1ee3c b\u1ed5 sung th\u00eam nhi\u1ec1u kh\u00e1ng th\u1ec3 c\u00f3 trong s\u1eefa m\u1eb9 giu\u0301p b\u00e9 kho\u1ebb m\u1ea1nh. Nh\u01b0ng trong c\u1ea3 hai tr\u01b0\u1eddng h\u1ee3p tr\u00ean th\u00ec s\u1ee9c b\u1ea3o v\u1ec7 cho b\u00e9 ch\u1ec9 l\u00e0 t\u1ea1m th\u1eddi trong m\u1ed9t th\u1eddi gian ng\u1eafn th\u00f4i.  Ch\u1ee7ng ng\u1eeba (ti\u00eam ch\u1ee7ng) l\u00e0 c\u00e1ch t\u1ea1o s\u1ee9c \u0111\u1ec1 kh\u00e1ng v\u1edbi m\u1ed9t s\u1ed1 b\u1ec7nh b\u1eb1ng c\u00e1ch s\u1eed d\u1ee5ng r\u1ea5t \u00edt vi sinh v\u1eadt \u0111\u00e3 ch\u1ebft ho\u1eb7c b\u1ecb l\u00e0m y\u1ebfu c\u00f3 th\u1ec3 g\u00e2y m\u1ed9t b\u1ec7nh c\u1ee5 th\u1ec3 n\u00e0o \u0111\u00f3.  Vi sinh v\u1eadt c\u00f3 th\u1ec3 l\u00e0 vi-ru\u0301t, nh\u01b0 vi-ru\u0301t s\u1edfi, ho\u1eb7c cu\u0303ng c\u00f3 th\u1ec3 l\u00e0 vi khu\u1ea9n, nh\u01b0 khu\u1ea9n c\u1ea7u ph\u1ed5i ch\u1eb3ng h\u1ea1n. C\u00e1c v\u1eafc-xin c\u00f3 t\u00e1c d\u1ee5ng l\u00e0m k\u00edch th\u00edch h\u1ec7 mi\u1ec5n d\u1ecbch ph\u1ea3n \u1ee9ng y nh\u01b0 b\u1ecb nhi\u1ec5m b\u1ec7nh th\u1eadt v\u1eady \u2013 h\u1ec7 mi\u1ec5n d\u1ecbch c\u1ee7a c\u01a1 th\u1ec3 lu\u0301c n\u00e0y s\u1ebd ch\u1ed1ng \u201cnhi\u1ec5m\u201d v\u00e0 c\u00f3 th\u1ec3 \u201cnh\u1edb \u0111\u01b0\u1ee3c\u201d lo\u1ea1i sinh v\u1eadt g\u00e2y b\u1ec7nh n\u00e0y \u0111\u1ec3 sau n\u00e0y c\u00f3 th\u1ec3 nhanh ch\u00f3ng di\u1ec7t \u0111\u01b0\u1ee3c n\u00f3 khi x\u00e2m nh\u1eadp v\u00e0o c\u01a1 th\u1ec3.  M\u1ed9t s\u1ed1 cha m\u1eb9 c\u00f3 th\u1ec3 l\u01b0\u1ee1ng l\u1ef1 kh\u00f4ng bi\u1ebft n\u00ean cho con m\u00ecnh ti\u00eam ng\u1eeba hay kh\u00f4ng b\u1edfi h\u1ecd lo r\u1eb1ng b\u00e9 s\u1ebd ph\u1ea3n \u1ee9ng l\u1ea1i v\u1eafc-xin m\u1ed9t c\u00e1ch tr\u1ea7m tr\u1ecdng ho\u1eb7c cu\u0303ng c\u00f3 th\u1ec3 b\u00e9 b\u1ecb b\u1ec7nh gi\u1ed1ng v\u1edbi b\u1ec7nh c\u1ea7n ti\u00eam ng\u1eeba. V\u00ec c\u00e1c th\u00e0nh ph\u1ea7n trong v\u1eafc-xin \u0111\u00e3 b\u1ecb l\u00e0m y\u1ebfu ho\u1eb7c \u0111\u00e3 ch\u1ebft \u2013 v\u00e0 trong m\u1ed9t v\u00e0i tr\u01b0\u1eddng h\u1ee3p th\u00ec kh\u00f4ng s\u1eed d\u1ee5ng h\u1ebft vi sinh v\u1eadt \u0111\u00f3 \u2013 chu\u0301ng kh\u00f3 c\u00f3 th\u1ec3 g\u00e2y ra m\u1ed9t ch\u1ee9ng b\u1ec7nh nguy hi\u1ec3m n\u00e0o. M\u1ed9t s\u1ed1 v\u1eafc-xin cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y ra ph\u1ea3n \u1ee9ng nh\u1eb9 nh\u01b0 \u0111au nh\u1ee9c vu\u0300ng ti\u00eam ho\u1eb7c l\u00e0m cho b\u00e9 n\u00f3ng s\u1ed1t, nh\u01b0ng c\u00e1c tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng n\u1eb7ng r\u1ea5t hi\u1ebfm x\u1ea3y ra.  Nh\u1eefng r\u1ee7i ro do ti\u00eam ng\u1eeba l\u00e0 r\u1ea5t \u00edt so v\u1edbi c\u00e1c v\u1ea5n \u0111\u1ec1 s\u1ee9c kh\u1ecfe do b\u1ec7nh m\u00e0 m\u00ecnh mu\u1ed1n ph\u00f2ng tr\u00e1nh g\u00e2y ra. L\u1ecbch ch\u1ee7ng ng\u1eeba d\u01b0\u1edbi \u0111\u00e2y do Vi\u1ec7n H\u00e0n L\u00e2m Nhi Khoa Hoa K\u1ef3 (AAP) khuy\u1ebfn ngh\u1ecb. Nh\u01b0ng xin l\u01b0u \u00fd l\u00e0 cu\u0303ng \u0111\u01b0\u1ee3c ph\u00e9p thay \u0111\u1ed5i v\u00e0 th\u01b0\u1eddng thay \u0111\u1ed5i khi c\u00f3 c\u00e1c lo\u1ea1i v\u1eafc-xin m\u1edbi ra \u0111\u1eddi. AAP cu\u0303ng khuy\u1ebfn ngh\u1ecb tr\u1ebb em n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin k\u1ebft h\u1ee3p (ch\u1edb kh\u00f4ng ph\u1ea3i l\u00e0 v\u1eafc-xin \u0111\u01a1n l\u1ebb) b\u1ea5t c\u1ee9 khi n\u00e0o c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c. Nhi\u1ec1u lo\u1ea1i v\u1eafc-xin k\u1ebft h\u1ee3p \u0111\u01b0\u1ee3c \u0111\u01b0a v\u00e0o s\u1eed d\u1ee5ng nh\u1eb1m giu\u0301p l\u00e0m gi\u1ea3m s\u1ed1 mu\u0303i ti\u00eam ch\u00edch cho tr\u1ebb.  B\u00e1c s\u0129 s\u1ebd quy\u1ebft \u0111\u1ecbnh xem l\u1ecbch ch\u1ee7ng ng\u1eeba n\u00e0o l\u00e0 t\u1ed1t nh\u1ea5t cho con c\u1ee7a b\u1ea1n.  L\u1ecbch ti\u00eam ch\u1ee7ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb nh\u01b0 sau: B\u1ec7nh vi\u00eam gan si\u00eau vi B Vi-ru\u0301t vi\u00eam gan si\u00eau vi B (HBV) l\u00e0m \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gan. B\u1ec7nh nh\u00e2n vi\u00eam gan si\u00eau vi B c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh ng\u01b0\u1eddi s\u1ed1ng v\u1edbi vi-ru\u0301t/ mang vi-ru\u0301t n\u00e0y su\u1ed1t \u0111\u1eddi v\u00e0 c\u00f3 th\u1ec3 ph\u00e1t sinh ra nhi\u1ec1u v\u1ea5n \u0111\u1ec1 l\u00e2u d\u00e0i nh\u01b0 l\u00e0 x\u01a1 gan (b\u1ec7nh gan) ho\u1eb7c ung th\u01b0 gan. L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin vi\u00eam gan si\u00eau vi B th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba m\u1ed9t lo\u1ea1t 3 mu\u0303i. Tr\u1ebb s\u01a1 sinh th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam mu\u0303i \u0111\u1ea7u ti\u00ean ngay sau khi ra \u0111\u1eddi. N\u1ebfu m\u1eb9 d\u01b0\u01a1ng t\u00ednh v\u1edbi vi-ru\u0301t vi\u00eam gan si\u00eau vi B trong m\u00e1u th\u00ec tr\u1ebb m\u1edbi sinh c\u1ea7n ph\u1ea3i \u0111\u01b0\u1ee3c ti\u00eam mu\u0303i \u0111\u1ea7u trong v\u00f2ng 12 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 sau khi l\u1ecdt l\u00f2ng m\u1eb9, cu\u0300ng v\u1edbi m\u1ed9t mu\u0303i (HBIG) kh\u00e1c \u0111\u1ec3 c\u00f3 th\u1ec3 kh\u00e1ng vi-ru\u0301t ngay l\u1eadp t\u1ee9c. N\u1ebfu m\u1eb9 \u00e2m t\u00ednh v\u1edbi vi-ru\u0301t vi\u00eam gan si\u00eau vi B th\u00ec tr\u1ebb s\u01a1 sinh cu\u0303ng c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba lo\u1ea1i v\u1eafc-xin n\u00e0y v\u00e0o b\u1ea5t c\u1ee9 lu\u0301c n\u00e0o tr\u01b0\u1edbc khi ra vi\u1ec7n. B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 ho\u00e3n l\u1ea1i mu\u0303i ch\u00edch n\u00e0y \u0111\u1ebfn l\u1ea7n kh\u00e1m b\u00e1c s\u0129 trong 1 hay 2 th\u00e1ng.  N\u1ebfu \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba li\u1ec1u \u0111\u1ea7u ti\u00ean sau khi sinh th\u00ec li\u1ec1u th\u1ee9 hai n\u00ean c\u00e1ch 1 \u0111\u1ebfn 2 th\u00e1ng v\u00e0 li\u1ec1u th\u1ee9 3 \u0111\u01b0\u1ee3c ti\u00eam t\u1eeb kho\u1ea3ng 6 \u0111\u1ebfn 18 th\u00e1ng. \u0110\u1ed1i v\u1edbi tr\u1ebb s\u01a1 sinh \u0111\u01b0\u1ee3c ti\u00eam mu\u0303i \u0111\u1ea7u ti\u00ean lu\u0301c 1 \u0111\u1ebfn 2 th\u00e1ng tu\u1ed5i th\u00ec mu\u0303i th\u1ee9 2 l\u00e0 kho\u1ea3ng t\u1eeb 3 \u0111\u1ebfn 4 th\u00e1ng v\u00e0 mu\u0303i th\u1ee9 ba t\u1eeb kho\u1ea3ng 6 th\u00e1ng 18 th\u00e1ng. Trong c\u1ea3 hai tr\u01b0\u1eddng h\u1ee3p th\u00ec mu\u0303i th\u1ee9 2 v\u00e0 th\u1ee9 3 th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam k\u1ebft h\u1ee3p v\u1edbi l\u1ecbch ch\u1ee7ng ng\u1eeba th\u01b0\u1eddng l\u1ec7 kh\u00e1c c\u1ee7a tr\u1ebb. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb du\u0300ng v\u1eafc-xin  V\u1eafc-xin vi\u00eam gan si\u00eau vi B th\u01b0\u1eddng c\u00f3 th\u1ec3 t\u1ea1o mi\u1ec5n d\u1ecbch l\u00e2u d\u00e0i. Tr\u1ebb s\u01a1 sinh \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng HBV s\u1ebd mi\u1ec5n nhi\u1ec5m vi\u00eam gan si\u00eau vi B kh\u00f4ng ch\u1ec9 trong th\u1eddi th\u01a1 \u1ea5u m\u00e0 c\u00f2n c\u1ea3 giai \u0111o\u1ea1n tu\u1ed5i tr\u01b0\u1edfng th\u00e0nh. N\u1ebfu lo\u1ea1i tr\u1eeb \u0111\u01b0\u1ee3c nguy c\u01a1 nhi\u1ec5m b\u1ec7nh, b\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 gi\u1ea3m nguy c\u01a1 b\u1ecb x\u01a1 gan, b\u1ecb b\u1ec7nh gan m\u00e3n t\u00ednh, v\u00e0 ung th\u01b0 gan. Thanh ni\u00ean v\u00e0 thanh thi\u1ebfu ni\u00ean cu\u0303ng n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin n\u00e0y n\u1ebfu nh\u01b0 ch\u01b0a \u0111\u01b0\u1ee3c ti\u00eam l\u1ea7n n\u00e0o lu\u0301c nh\u1ecf.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin l\u00e0 r\u1ea5t \u00edt. C\u00e1c v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng li\u00ean quan \u0111\u1ebfn vi\u1ec7c ti\u00eam ng\u1eeba v\u1eafc-xin HBV r\u1ea5t hi\u1ebfm x\u1ea3y ra. Ph\u1ea3n \u1ee9ng sau khi ti\u00eam ng\u1eeba th\u01b0\u1eddng l\u00e0 r\u1ea5t nh\u1eb9, nh\u01b0 n\u00f3ng s\u1ed1t ho\u1eb7c n\u1ed5i \u0111\u1ecf ho\u1eb7c b\u1ecb \u0111au t\u1ea1i vu\u0300ng ti\u00eam ch\u00edch.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c kh\u00f4ng ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng (g\u1ecdi l\u00e0 s\u1ed1c m\u1eabn c\u1ea3m) sau l\u1ea7n ti\u00eam v\u1eafc-xin HBV tr\u01b0\u1edbc \u0111\u00e2y  Ch\u0103m s\u00f3c cho con b\u1ea1n sau khi ti\u00eam ng\u1eeba V\u1eafc-xin c\u00f3 th\u1ec3 g\u00e2y s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam ng\u1eeba. Tu\u0300y v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a b\u00e9 m\u00e0 b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 l\u00e0m gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. Tr\u1ebb s\u01a1 sinh r\u1ea5t nh\u1ecf kh\u00f4ng n\u00ean du\u0300ng thu\u1ed1c, nh\u01b0ng \u0111\u1ed1i v\u1edbi tr\u1ebb s\u01a1 sinh l\u1edbn h\u01a1n ho\u1eb7c tr\u1ebb nh\u1ecf th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 thu\u1ed1c v\u00e0 li\u1ec1u du\u0300ng th\u00edch h\u1ee3p cho b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n ch\u01b0a r\u00f5 v\u1ec1 l\u1ecbch ch\u1ee7ng ng\u1eeba v\u1eafc-xin vi\u00eam gan si\u00eau vi B  * n\u1ebfu b\u1ea1n lo l\u1eafng v\u1ec1 t\u00ecnh tr\u1ea1ng mang m\u1ea7m vi-ru\u0301t HBV c\u1ee7a m\u00ecnh * n\u1ebfu b\u1ea1n th\u1ea5y b\u1ea5t c\u1ee9 tri\u1ec7u ch\u1ee9ng \u1ea3nh h\u01b0\u1edfng x\u1ea5u nghi\u00eam tr\u1ecdng n\u00e0o \u0111\u1ed1i v\u1edbi con b\u1ea1n sau khi b\u00e9 ti\u00eam ng\u1eeba HBV V\u1eafc-xin ch\u1ed1ng khu\u1ea9n c\u1ea7u ph\u1ed5i (PCV) V\u1eafc-xin c\u1ed9ng h\u1ee3p ph\u1ebf c\u1ea7u (PCV) c\u00f3 t\u00e1c d\u1ee5ng ch\u1ed1ng nhi\u1ec5m khu\u1ea9n c\u1ea7u ph\u1ed5i. Vi khu\u1ea9n l\u00e0 nguy\u00ean nh\u00e2n h\u00e0ng \u0111\u1ea7u c\u1ee7a nhi\u1ec1u ch\u1ee9ng nhi\u1ec5m tru\u0300ng nghi\u00eam tr\u1ecdng, nh\u01b0 vi\u00eam ph\u1ed5i, nhi\u1ec5m tru\u0300ng m\u00e1u, v\u00e0 vi\u00eam m\u00e0ng n\u00e3o do vi khu\u1ea9n. Tr\u1ebb em d\u01b0\u1edbi 2 tu\u1ed5i, ng\u01b0\u1eddi l\u1edbn tr\u00ean 65 tu\u1ed5i, v\u00e0 ng\u01b0\u1eddi \u0111ang m\u1eafc m\u1ed9t s\u1ed1 b\u1ec7nh n\u00e0o \u0111\u00f3 d\u1ec5 b\u1ecb nhi\u1ec5m khu\u1ea9n c\u1ea7u ph\u1ed5i nhi\u1ec1u nh\u1ea5t. khu\u1ea9n c\u1ea7u ph\u1ed5i l\u00e2y qua ti\u1ebfp xu\u0301c t\u1eeb ng\u01b0\u1eddi sang ng\u01b0\u1eddi. V\u1eafc-xin c\u1ed9ng h\u1ee3p ph\u1ebf c\u1ea7u kh\u00f4ng nh\u1eefng giu\u0301p tr\u1ebb tr\u00e1nh nhi\u1ec5m b\u1ec7nh m\u00e0 c\u00f2n ng\u0103n ch\u1eb7n l\u00e2y lan.  L\u1ecbch ch\u1ee7ng ng\u1eeba Ch\u1ee7ng ng\u1eeba PCV \u0111\u01b0\u1ee3c ti\u00eam th\u00e0nh m\u1ed9t lo\u1ea1t 4 mu\u0303i, b\u1eaft \u0111\u1ea7u t\u1eeb 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u1ed5i, 6 th\u00e1ng tu\u1ed5i, v\u00e0 t\u1eeb 12 \u0111\u1ebfn 15 th\u00e1ng tu\u1ed5i. Tr\u1ebb b\u1ecf l\u1ee1 li\u1ec1u v\u1eafc-xin \u0111\u1ea7u ti\u00ean ho\u1eb7c c\u00f3 th\u1ec3 \u0111\u00e3 kh\u00f4ng ch\u00edch \u0111\u01b0\u1ee3c c\u00e1c li\u1ec1u sau do thi\u1ebfu v\u1eafc-xin th\u00ec v\u1eabn s\u1ebd \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba, v\u00e0 b\u00e1c s\u0129 s\u1ebd cho b\u1ea1n bi\u1ebft l\u1ecbch ti\u00eam ch\u1ee7ng c\u00f3 thay \u0111\u1ed5i c\u1ee7a m\u00ecnh. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb du\u0300ng v\u1eafc-xin  tr\u1ebb d\u01b0\u1edbi 2 tu\u1ed5i th\u01b0\u1eddng hay m\u1eafc h\u1ea7u h\u1ebft c\u00e1c b\u1ec7nh nhi\u1ec5m tru\u0300ng n\u1eb7ng, v\u00e0 v\u1eafc-xin s\u1ebd giu\u0301p cho tr\u1ebb ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c c\u00e1c b\u1ec7nh \u0111\u00f3 khi c\u00f3 nguy c\u01a1 l\u00e2y nhi\u1ec5m nhi\u1ec1u nh\u1ea5t.  PCV cu\u0303ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb ti\u00eam ph\u00f2ng cho tr\u1ebb t\u1eeb 2 \u0111\u1ebfn 5 tu\u1ed5i \u0111ang c\u00f3 nguy c\u01a1 nhi\u1ec5m khu\u1ea9n c\u1ea7u ph\u1ed5i n\u1eb7ng v\u00ec c\u00f3 th\u1ec3 g\u00e2y nhi\u1ec1u v\u1ea5n \u0111\u1ec1 v\u1ec1 s\u1ee9c kh\u1ecfe nh\u01b0:  * b\u1ec7nh thi\u1ebfu m\u00e1u h\u1ed3ng c\u1ea7u h\u00ecnh li\u1ec1m * l\u00e1 l\u00e1ch b\u1ecb h\u01b0 ho\u1eb7c kh\u00f4ng c\u00f3 l\u00e1 l\u00e1ch * HIV/AIDS * ph\u1ea3i du\u0300ng thi\u1ebft b\u1ecb tr\u1ee3 th\u00ednh \u0111\u01b0\u1ee3c c\u1ea5y d\u01b0\u1edbi da * b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 ti\u1ec3u \u0111\u01b0\u1eddng ho\u1eb7c ung th\u01b0 * ph\u1ea3i du\u0300ng thu\u1ed1c \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 l\u00e0 xt\u00ea-r\u00f4-it ho\u1eb7c ho\u00e1 tr\u1ecb li\u1ec7u * b\u1ecb b\u1ec7nh tim m\u00e3n t\u00ednh ho\u1eb7c b\u1ec7nh v\u1ec1 ph\u1ed5i Ngo\u00e0i ra, nh\u1eefng tr\u1ebb em c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao cu\u0303ng c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba v\u1eafc-xin p\u00f4-li-xa-ca-r\u00edt khu\u1ea9n c\u1ea7u ph\u1ed5i (PPV) ngo\u00e0i v\u1eafc-xin PCV khi \u0111\u00e3 tr\u00ean 24 th\u00e1ng tu\u1ed5i.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra Tr\u1ebb \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba v\u1eafc-xin PCV cu\u0303ng c\u00f3 th\u1ec3 b\u1ecb n\u1ed5i \u0111\u1ecf, \u0111au nh\u1ee9c, ho\u1eb7c s\u01b0ng \u1edf vu\u0300ng ti\u00eam ho\u1eb7c cu\u0303ng c\u00f3 th\u1ec3 b\u1ecb n\u00f3ng s\u1ed1t sau khi ti\u00eam ng\u1eeba. Tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin r\u1ea5t hi\u1ebfm khi x\u1ea3y ra.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u v\u1eafc-xin tr\u01b0\u1edbc  Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba V\u1eafc-xin n\u00e0y c\u00f3 th\u1ec3 g\u00e2y s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen hay ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 xem li\u1ec7u c\u00f3 th\u1ec3 cho b\u00e9 du\u0300ng thu\u1ed1c g\u00ec, v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p v\u1edbi b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu con b\u1ea1n b\u1ecf l\u1ee1 m\u1ed9t l\u1ea7n ti\u00eam * n\u1ebfu sau khi ti\u00eam ng\u1eeba b\u00e9 b\u1ecb ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng ho\u1eb7c s\u1ed1t cao DTaP V\u1eafc-xin DTaP giu\u0301p ph\u00f2ng tr\u00e1nh: * b\u1ea1ch h\u1ea7u \u2013 \u0111\u00e2y l\u00e0 ch\u1ee9ng nhi\u1ec5m tru\u0300ng h\u1ecdng nghi\u00eam tr\u1ecdng c\u00f3 th\u1ec3 g\u00e2y ngh\u1ebdn \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p hay ngh\u1ebdn kh\u00ed qu\u1ea3n v\u00e0 g\u00e2y kh\u00f3 th\u1edf d\u1eef d\u1ed9i  * u\u1ed1n v\u00e1n \u2013 \u0111\u00e2y l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh th\u1ea7n kinh, c\u00f3 th\u1ec3 x\u1ea3y ra \u1edf m\u1ecdi l\u1ee9a tu\u1ed5i, do \u0111\u1ed9c t\u1ed1 t\u1ea1o khu\u1ea9n l\u00e0m nhi\u1ec5m tru\u0300ng v\u1ebft th\u01b0\u01a1ng (u\u1ed1n v\u00e1n l\u00e0 m\u1ed9t b\u1ec7nh do vi khu\u1ea9n qua v\u1ebft th\u01b0\u01a1ng x\u00e2m nh\u1eadp v\u00e0o c\u01a1 th\u1ec3, g\u00e2y n\u00ean nh\u1eefng c\u01a1n co gi\u1eadt, kh\u00f3 th\u1edf v\u00e0 d\u1ec5 d\u1eabn \u0111\u1ebfn t\u1eed vong) * ho g\u00e0 \u2013 l\u00e0 m\u1ed9t b\u1ec7nh v\u1ec1 \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p v\u1edbi c\u00e1c tri\u1ec7u ch\u1ee9ng c\u1ee7a b\u1ec7nh cu\u0301m ph\u00e1t tri\u1ec3n ng\u00e0y c\u00e0ng t\u0103ng d\u1eabn \u0111\u1ebfn ho d\u1eef d\u1ed9i (nghe nh\u01b0 ti\u1ebfng kh\u00f2 kh\u00e8 khi tr\u1ebb h\u00edt s\u00e2u v\u00e0o sau m\u1ed9t c\u01a1n ho ru\u0303 r\u01b0\u1ee3i); tr\u1ebb d\u01b0\u1edbi 1 tu\u1ed5i th\u01b0\u1eddng x\u1ea3y ra nhi\u1ec1u bi\u1ebfn ch\u1ee9ng ho g\u00e0 tr\u1ea7m tr\u1ecdng, v\u00e0 tr\u1ebb d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i cu\u0303ng r\u1ea5t hay nhi\u1ec5m b\u1ec7nh n\u00e0y. Thi\u1ebfu ni\u00ean v\u00e0 ng\u01b0\u1eddi l\u1edbn b\u1ecb ho dai d\u1eb3ng cu\u0303ng c\u00f3 th\u1ec3 kh\u00f4ng bi\u1ebft m\u00ecnh b\u1ecb ho g\u00e0, v\u00e0 cu\u0303ng c\u00f3 th\u1ec3 l\u00e0m l\u00e2y sang cho tr\u1ebb s\u01a1 sinh d\u1ec5 m\u1eafc b\u1ec7nh.  L\u1ecbch ch\u1ee7ng ng\u1eeba Ch\u1ee7ng ng\u1eeba DTaP \u0111\u01b0\u1ee3c ti\u00eam th\u00e0nh 1 lo\u1ea1t 5 mu\u0303i v\u00e0 th\u01b0\u1eddng b\u1eaft \u0111\u1ea7u lu\u0301c 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u1ed5i, 6 th\u00e1ng tu\u1ed5i, t\u1eeb 15 \u0111\u1ebfn 18 th\u00e1ng tu\u1ed5i, v\u00e0 t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i. Sau lo\u1ea1t ch\u1ee7ng ng\u1eeba \u0111\u1ea7u ti\u00ean, v\u1eafc-xin Tdap (ti\u00eam nh\u1eafc) s\u1ebd \u0111\u01b0\u1ee3c ti\u00eam nh\u1eafc l\u1ea1i cho \u0111\u1ed9 tu\u1ed5i t\u1eeb 11 \u0111\u1ebfn 12, ho\u1eb7c cho thi\u1ebfu ni\u00ean l\u1edbn tu\u1ed5i h\u01a1n v\u00e0 ng\u01b0\u1eddi l\u1edbn ch\u01b0a ti\u00eam nh\u1eafc ng\u1eeba b\u1ec7nh ho g\u00e0 l\u1ea1i. K\u1ebf \u0111\u1ebfn l\u00e0 c\u00e1c mu\u0303i ti\u00eam nh\u1eafc ng\u1eeba u\u1ed1n v\u00e1n, b\u1ea1ch h\u1ea7u cu\u0303ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb l\u00e0 c\u1ee9 sau 10 n\u0103m m\u1ed9t l\u1ea7n.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Vi\u1ec7c ch\u1ee7ng ng\u1eeba v\u1eafc-xin DtaP h\u1ea7u nh\u01b0 \u0111\u00e3 giu\u0301p tr\u1ebb kh\u00f4ng c\u00f2n m\u1eafc b\u1ec7nh b\u1ea1ch h\u1ea7u v\u00e0 u\u1ed1n v\u00e1n \u1edf tr\u1ebb em v\u00e0 \u0111\u00e3 l\u00e0m gi\u1ea3m \u0111\u00e1ng k\u1ec3 s\u1ed1 ca m\u1eafc ch\u1ee9ng ho g\u00e0. R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra V\u1eafc-xin ch\u1ee7ng ng\u1eeba th\u01b0\u1eddng g\u00e2y t\u00e1c d\u1ee5ng ph\u1ee5 nh\u1eb9 nh\u01b0 n\u00f3ng s\u1ed1t, h\u01a1i m\u1ec7t, m\u1ec7t m\u1ecfi, ch\u00e1n \u0103n, v\u00e0 \u0111au nh\u1ee9c, n\u1ed5i \u0111\u1ecf ho\u1eb7c l\u00e0m s\u01b0ng \u1edf vu\u0300ng ti\u00eam. C\u00e1c tr\u01b0\u1eddng h\u1ee3p tai bi\u1ebfn ng\u1eadp m\u00e1u hay ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng sau khi ti\u00eam DTaP l\u00e0 r\u1ea5t hi\u1ebfm x\u1ea3y ra. H\u1ea7u h\u1ebft c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 n\u00e0y l\u00e0 do c\u00e1c th\u00e0nh ph\u1ea7n trong v\u1eafc-xin ng\u1eeba ho g\u00e0. C\u00e1c bi\u1ebfn ch\u1ee9ng nghi\u00eam tr\u1ecdng do ch\u1ee7ng ng\u1eeba DTaP r\u1ea5t hi\u1ebfm. Ph\u1ea7n l\u1edbn tr\u1ebb em \u0111\u1ec1u g\u1eb7p r\u1ea5t \u00edt s\u1ef1 c\u1ed1 ho\u1eb7c kh\u00f4ng c\u00f3 v\u1ea5n \u0111\u1ec1 g\u00ec. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba  * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb \u0111\u1ed9ng kinh kh\u00f4ng k\u1ec1m ch\u1ebf \u0111\u01b0\u1ee3c ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh th\u1ea7n kinh n\u00e0o \u0111\u00f3 ho\u1eb7c c\u00f3 v\u1ebb nh\u01b0 ph\u00e1t tri\u1ec3n kh\u00f4ng b\u00ecnh th\u01b0\u1eddng th\u00ec cu\u0303ng kh\u00f4ng n\u00ean ti\u1ebfp xu\u0301c v\u1edbi v\u1eafc-xin ho g\u00e0, b\u00e9 c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ti\u00eam v\u1eafc-xin DT (b\u1ea1ch h\u1ea7u, u\u1ed1n v\u00e1n) thay cho v\u1eafc-xin DTaP.  N\u1ebfu con b\u1ea1n b\u1ecb b\u1ea5t k\u1ef3 tri\u1ec7u ch\u1ee9ng g\u00ec sau khi ti\u00eam DTaP \u1edf l\u1ea7n tr\u01b0\u1edbc, b\u1ea1n h\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 tr\u01b0\u1edbc khi cho b\u00e9 ti\u00eam m\u1ed9t lo\u1ea1i v\u1eafc-xin n\u00e0o kh\u00e1c nh\u00e9: * tai bi\u1ebfn ng\u1eadp m\u00e1u trong v\u00f2ng 7 ng\u00e0y sau khi ti\u00eam * tai bi\u1ebfn ng\u1eadp m\u00e1u ng\u00e0y c\u00e0ng d\u1eef d\u1ed9i h\u01a1n * ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng sau khi ti\u00eam v\u1eafc-xin, nh\u01b0 l\u00e0 mi\u1ec7ng, h\u1ecdng, ho\u1eb7c m\u1eb7t s\u01b0ng l\u00ean  * kh\u00f3 th\u1edf * s\u1ed1t 105\u00b0 Pha-ren-het (40.5\u00b0 C) tr\u1edf l\u00ean trong 2 ng\u00e0y \u0111\u1ea7u sau khi ti\u00eam  * s\u1ed1c ho\u1eb7c suy nh\u01b0\u1ee3c trong 2 ng\u00e0y \u0111\u1ea7u ti\u00ean sau khi ti\u00eam * kh\u00f3c dai d\u1eb3ng kh\u00f4ng n\u00edn h\u01a1n 3 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 trong 2 ng\u00e0y \u0111\u1ea7u ti\u00ean sau khi ti\u00eam Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba Con b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb n\u00f3ng s\u1ed1t, \u0111au nh\u1ee9c v\u00e0 s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 l\u00e0m gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n h\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 cho b\u00e9 s\u1eed d\u1ee5ng lo\u1ea1i thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o cho phu\u0300 h\u1ee3p v\u1edbi b\u00e9 nh\u00e9. B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 du\u0300ng mi\u1ebfng gi\u1ebb \u1ea9m, \u1ea5m ho\u1eb7c mi\u1ebfng l\u00f3t n\u00f3ng \u0111\u1ec3 l\u00e0m gi\u1ea3m \u0111au. Vi\u1ec7c nhu\u0301c nh\u00edch, c\u1eed \u0111\u1ed9ng ch\u00e2n tay c\u00f3 vu\u0300ng ti\u00eam ng\u1eeba cu\u0303ng th\u01b0\u1eddng giu\u0301p b\u1ea1n gi\u1ea3m \u0111au. Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129 * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh v\u1eafc-xin ch\u1ee7ng ng\u1eeba n\u00e0y hay kh\u00f4ng. Tr\u1ebb em t\u1eebng g\u1eb7p s\u1ef1 c\u1ed1 n\u00e0o \u0111\u00f3 v\u1edbi v\u1eafc-xin DtaP th\u01b0\u1eddng c\u00f3 th\u1ec3 ti\u00eam ng\u1eeba an to\u00e0n v\u1edbi v\u1eafc-xin DT.  * n\u1ebfu x\u1ea3y ra c\u00e1c bi\u1ebfn ch\u1ee9ng hay c\u00e1c tri\u1ec7u ch\u1ee9ng tr\u1ea7m tr\u1ecdng sau khi ti\u00eam ng\u1eeba nh\u01b0 tai bi\u1ebfn ng\u1eadp m\u00e1u, s\u1ed1t tr\u00ean 105\u00b0 Pha-ren-het (40.5\u00b0 C), kh\u00f3 th\u1edf ho\u1eb7c c\u00f3 c\u00e1c d\u1ea5u hi\u1ec7u d\u1ecb \u1ee9ng kh\u00e1c, s\u1ed1c hay b\u1ea5t t\u1ec9nh (x\u1ec9u), ho\u1eb7c kh\u00f3c dai d\u1eb3ng kh\u00f4ng n\u00edn h\u01a1n 3 ti\u1ebfng \u0111\u1ed3ng h\u1ed3 Hib Tr\u01b0\u1edbc khi v\u1eafc-xin Hib ra \u0111\u1eddi th\u00ec vi khu\u1ea9n g\u00e2y vi\u00eam m\u00e0ng n\u00e3o mu\u0303 do HIB lo\u1ea1i B l\u00e0 nguy\u00ean nh\u00e2n h\u00e0ng \u0111\u1ea7u g\u00e2y vi\u00eam m\u00e0ng n\u00e3o \u1edf tr\u1ebb d\u01b0\u1edbi 5 tu\u1ed5i.\u00a0  L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin Hib \u0111\u01b0\u1ee3c ti\u00eam \u1edf giai \u0111o\u1ea1n 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u00f4it, v\u00e0 6 th\u00e1ng tu\u1ed5i (tuy nhi\u00ean, m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin Hib kh\u00f4ng y\u00eau c\u1ea7u ph\u1ea3i ti\u00eam th\u00eam li\u1ec1u \u1edf th\u00e1ng th\u1ee9 6). Tr\u1ebb n\u00ean \u0111\u01b0\u1ee3c ti\u00eam nh\u1eafc l\u1ea1i m\u1ed9t l\u1ea7n t\u1eeb th\u00e1ng 12 \u0111\u1ebfn th\u00e1ng 15.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin V\u1eafc-xin Hib c\u00f3 th\u1ec3 giu\u0301p ph\u00f2ng tr\u00e1nh vi\u00eam m\u00e0ng n\u00e3o mu\u0303 do HIB lo\u1ea1i B trong th\u1eddi gian l\u00e2u d\u00e0i. Ng\u01b0\u1eddi \u0111\u01b0\u1ee3c ch\u1ee7ng ng\u1eeba tr\u00e1nh \u0111\u01b0\u1ee3c b\u1ec7nh vi\u00eam m\u00e0ng n\u00e3o Hib, vi\u00eam ph\u1ed5i, vi\u00eam m\u00e0ng ngo\u00e0i tim (vi\u00eam m\u00e0ng tim), v\u00e0 nhi\u1ec5m tru\u0300ng m\u00e1u, x\u01b0\u01a1ng v\u00e0 kh\u1edbp do vi khu\u1ea9n g\u00e2y ra.\u00a0  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra Cu\u0303ng c\u00f3 nhi\u1ec1u v\u1ea5n \u0111\u1ec1 nh\u1ecf sau khi ti\u00eam ng\u1eeba, nh\u01b0 b\u00e9 s\u1ebd c\u00f3 th\u1ec3 n\u1ed5i \u0111\u1ecf, s\u01b0ng ho\u1eb7c \u0111au nh\u1ee9c \u1edf vu\u0300ng ti\u00eam. Tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin r\u1ea5t hi\u1ebfm khi x\u1ea3y ra. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng sau khi ti\u00eam v\u1eafc-xin Hib th\u00ec ch\u1edb n\u00ean cho b\u00e9 ti\u00eam th\u00eam Hib l\u1ea7n sau n\u1eefa Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba V\u1eafc-xin Hib c\u00f3 th\u1ec3 g\u00e2y \u0111au nh\u1ee9c nh\u1eb9 hay n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u n\u00ean cho b\u00e9 du\u0300ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p v\u1edbi b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi \u0111i\u1ec7n cho b\u00e1c s\u0129 * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh kh\u00f4ng ti\u00eam ng\u1eeba lo\u1ea1i v\u1eafc-xin n\u00e0y * n\u1ebfu th\u1ea5y c\u00e1c ph\u1ea3n \u1ee9ng x\u1ea5u nghi\u00eam tr\u1ecdng sau khi ti\u00eam ng\u1eeba Hib  IPV B\u1ec7nh b\u1ea1i li\u1ec7t l\u00e0 b\u1ec7nh nhi\u1ec5m vi-ru\u0301t c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn b\u1ea1i li\u1ec7t su\u1ed1t \u0111\u1eddi. L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin ng\u1eeba b\u1ea1i li\u1ec7t b\u1ea5t ho\u1ea1t th\u01b0\u1eddng \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba \u1edf giai \u0111o\u1ea1n 2 th\u00e1ng tu\u1ed5i, 4 th\u00e1ng tu\u1ed5i, t\u1eeb 6 th\u00e1ng \u0111\u1ebfn 18 th\u00e1ng tu\u1ed5i, v\u00e0 t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i.  G\u1ea7n \u0111\u00e2y v\u1eafc-xin ng\u1eeba b\u1ea1i li\u1ec7t d\u1ea1ng u\u1ed1ng \u0111\u00e3 \u0111\u01b0\u1ee3c \u0111\u01b0a v\u00e0o s\u1eed d\u1ee5ng \u1edf Hoa K\u1ef3. U\u1ef7 ban c\u1ed1 v\u1ea5n v\u1ec1 ch\u1ee7ng ng\u1eeba m\u1edbi \u0111\u00e2y \u0111\u00e3 y\u00eau c\u1ea7u n\u00ean ti\u00eam IPV. S\u1ef1 thay \u0111\u1ed5i n\u00e0y \u0111\u00e3 l\u00e0m d\u1ee9t nguy c\u01a1 r\u1ea5t \u00edt v\u1ec1 b\u1ec7nh b\u1ea1i li\u1ec7t tr\u01b0\u1edbc \u0111\u00e2y sau khi du\u0300ng v\u1eafc-xin b\u1ea1i li\u1ec7t s\u1ed1ng d\u1ea1ng u\u1ed1ng. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin V\u1eafc-xin giu\u0301p ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c b\u1ec7nh b\u1ea1i li\u1ec7t c\u00f3 th\u1ec3 g\u00e2y li\u1ec7t v\u00e0 t\u1eed vong. R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 nh\u01b0 n\u00f3ng s\u1ed1t v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. R\u1ea5t \u00edt khi x\u1ea3y ra ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * kh\u00f4ng n\u00ean ti\u00eam IPV cho tr\u1ebb b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi neomycin, streptomycin, ho\u1eb7c polymyxin B. * kh\u00f4ng n\u00ean ti\u00eam IPV cho tr\u1ebb b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u ti\u00eam IPV tr\u01b0\u1edbc Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba IPV c\u00f3 th\u1ec3 g\u00e2y ra s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam trong m\u1ed9t v\u00e0i ng\u00e0y. Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n, b\u00e1c s\u0129 s\u1ebd cho thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem n\u00ean cho b\u00e9 s\u1eed d\u1ee5ng lo\u1ea1i thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u du\u0300ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u n\u00ean ho\u00e3n hay kh\u00f4ng ti\u00eam ch\u1ee7ng lo\u1ea1i v\u1eafc-xin n\u00e0y * n\u1ebfu c\u00f3 b\u1ea5t k\u1ef3 ph\u1ea3n \u1ee9ng x\u1ea5u nghi\u00eam tr\u1ecdng n\u00e0o x\u1ea3y ra sau khi ti\u00eam ng\u1eeba Cu\u0301m Cu\u0301m l\u00e0 ch\u1ee9ng b\u1ec7nh nhi\u1ec5m tru\u0300ng \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p do vi ru\u0301t g\u00e2y ra v\u00e0 l\u00e2y lan r\u1ea5t nhanh. L\u1ecbch ch\u1ee7ng ng\u1eeba B\u1eaft \u0111\u1ea7u mu\u0300a cu\u0301m 2010-2011 m\u1edbi c\u00f3 v\u1eafc-xin cu\u0301m mu\u0300a ng\u1eeba cu\u0301m H1N1 cu\u0303ng nh\u01b0 c\u00e1c lo\u1ea1i vi ru\u0301t cu\u0301m kh\u00e1c. Trung t\u00e2m ph\u00f2ng ch\u1ed1ng b\u1ec7nh t\u1eadt (CDC) khuy\u1ebfn c\u00e1o n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin cu\u0301m cho t\u1ea5t c\u1ea3 m\u1ecdi ng\u01b0\u1eddi t\u1eeb 6 th\u00e1ng tu\u1ed5i tr\u1edf l\u00ean. M\u1ed9t s\u1ed1 ng\u01b0\u1eddi c\u00f3 nguy c\u01a1 bi\u1ebfn ch\u1ee9ng cu\u0301m cao h\u01a1n g\u1ed3m:  * ph\u1ee5 n\u1eef c\u00f3 thai * tre\u0309 em d\u01b0\u1edbi 5 tu\u1ed5i, nh\u1ea5t l\u00e0 tr\u1ebb d\u01b0\u1edbi 2 tu\u1ed5i * ng\u01b0\u1eddi gi\u00e0 t\u1eeb 65 tu\u1ed5i tr\u1edf l\u00ean * ng\u01b0\u1eddi b\u1ecb b\u1ec7nh m\u00e3n t\u00ednh \u1edf b\u1ea5t k\u1ef3 \u0111\u1ed9 tu\u1ed5i n\u00e0o Tr\u1ebb s\u01a1 sinh d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i qu\u00e1 nh\u1ecf kh\u00f4ng ti\u00eam ng\u1eeba v\u1eafc-xin \u0111\u01b0\u1ee3c, nh\u01b0ng t\u1ea5t c\u1ea3 nh\u1eefng ng\u01b0\u1eddi c\u00f3 nguy c\u01a1 m\u1eafc b\u1ec7nh cao kh\u00e1c n\u00ean \u0111\u01b0\u1ee3c ti\u00eam ph\u00f2ng. C\u00e1c nh\u00e2n vi\u00ean ch\u0103m s\u00f3c y t\u1ebf, ng\u01b0\u1eddi ch\u0103m b\u1ec7nh, v\u00e0 ng\u01b0\u1eddi th\u01b0\u1eddng hay ti\u1ebfp xu\u0301c g\u1ea7n gu\u0303i v\u1edbi ng\u01b0\u1eddi c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao (k\u1ec3 c\u1ea3 ng\u01b0\u1eddi ch\u0103m s\u00f3c tr\u1ebb s\u01a1 sinh d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i) cu\u0303ng n\u00ean ti\u00eam ng\u1eeba v\u1eafc-xin. Tr\u01b0\u1edbc \u0111\u00e2y \u0111\u00e3 c\u00f3 t\u00ecnh tr\u1ea1ng thi\u1ebfu v\u00e0 ph\u1ea3i ho\u00e3n v\u1eafc-xin. V\u00ec v\u1eady b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 xem v\u1eafc-xin c\u00f3 s\u1eb5n ch\u01b0a nh\u00e9.  \u0110\u1ed1i v\u1edbi tr\u1ebb d\u01b0\u1edbi 9 tu\u1ed5i chu\u1ea9n b\u1ecb ti\u00eam ng\u1eeba v\u1eafc-xin cu\u0301m mu\u0300a l\u1ea7n \u0111\u1ea7u ti\u00ean ho\u1eb7c ch\u01b0a ti\u00eam ch\u1ee7ng v\u1eafc-xin H1N1 trong mu\u0300a cu\u0301m n\u0103m 2009-2010 th\u00ec s\u1ebd \u0111\u01b0\u1ee3c ti\u00eam th\u00e0nh 2 mu\u0303i ri\u00eang bi\u1ec7t c\u00e1ch nhau 1 th\u00e1ng. C\u00f3 th\u1ec3 ph\u1ea3i m\u1ea5t kho\u1ea3ng 2 tu\u1ea7n sau khi ti\u00eam v\u1eafc-xin th\u00ec c\u01a1 th\u1ec3 m\u1edbi c\u00f3 th\u1ec3 mi\u1ec5n d\u1ecbch \u0111\u01b0\u1ee3c v\u1edbi cu\u0301m.  B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 ch\u1ecdn m\u1ed9t d\u1ea1ng v\u1eafc-xin ph\u00f2ng ch\u1ed1ng cu\u0301m kh\u00e1c m\u00e0 kh\u00f4ng ph\u1ea3i ti\u00eam ch\u00edch \u0111\u00f3 l\u00e0 v\u1eafc-xin d\u1ea1ng x\u1ecbt v\u00e0o mu\u0303i \u0111\u00e3 \u0111\u01b0\u1ee3c tung ra th\u1ecb tr\u01b0\u1eddng n\u0103m 2003 \u0111\u1ec3 ng\u1eeba d\u1ecbch cu\u0301m mu\u0300a v\u00e0 hi\u1ec7n \u0111ang \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 ch\u1ed1ng cu\u0301m cho ng\u01b0\u1eddi kh\u1ecfe m\u1ea1nh t\u1eeb 2 \u0111\u1ebfn 49 tu\u1ed5i. V\u1eafc-xin d\u1ea1ng x\u1ecbt v\u00e0o mu\u0303i ch\u1ee9a vi-ru\u0301t c\u00f2n s\u1ed1ng nh\u01b0ng \u0111\u00e3 b\u1ecb l\u00e0m y\u1ebfu \u0111i v\u00e0 s\u1ebd kh\u00f4ng g\u00e2y cu\u0301m. Tuy nhi\u00ean, tr\u1ebb b\u1ecb m\u1eafc m\u1ed9t ch\u1ee9ng b\u1ec7nh n\u00e0o \u0111\u00f3 ho\u1eb7c ph\u1ee5 n\u1eef c\u00f3 thai th\u00ec kh\u00f4ng n\u00ean s\u1eed d\u1ee5ng d\u1ea1ng v\u1eafc-xin n\u00e0y. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 bi\u1ebft lo\u1ea1i v\u1eafc-xin n\u00e0o l\u00e0 phu\u0300 h\u1ee3p cho con c\u1ee7a m\u00ecnh nh\u00e9.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin  V\u1eafc-xin ng\u1eeba cu\u0301m c\u00f3 th\u1ec3 giu\u0301p l\u00e0m gi\u1ea3m nguy c\u01a1 m\u1eafc b\u1ec7nh \u0111\u1ebfn 80% trong mu\u0300a cu\u0301m. Vi\u1ec7c ti\u00eam ng\u1eeba \u0111\u1ee7 li\u1ec1u tr\u01b0\u1edbc mu\u0300a cu\u0301m giu\u0301p cho c\u01a1 th\u1ec3 t\u0103ng s\u1ee9c \u0111\u1ec1 kh\u00e1ng, t\u0103ng c\u01b0\u1eddng s\u1ef1 mi\u1ec5n d\u1ecbch cho c\u01a1 th\u1ec3 kh\u00e1ng l\u1ea1i vi-ru\u0301t.  v\u1eafc-xin th\u01b0\u1eddng c\u00f3 v\u00e0o gi\u1eefa th\u00e1ng 9 v\u00e0 gi\u1eefa th\u00e1ng 11. M\u1eb7c du\u0300 l\u00e0 b\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 ti\u00eam ph\u00f2ng v\u1eafc-xin cu\u0301m v\u00e0o mu\u0300a cu\u0301m nh\u01b0ng t\u1ed1t h\u01a1n h\u1ebft l\u00e0 n\u00ean ti\u00eam ch\u1ee7ng s\u1edbm h\u01a1n l\u00e0 mu\u1ed9n. Tuy nhi\u00ean th\u00ec b\u1ea1n cu\u0303ng v\u1eabn n\u00ean ti\u00eam ph\u00f2ng v\u00e0o cu\u1ed1i mu\u0300a cu\u0301m.  D\u1eabu b\u1ea1n hay con b\u1ea1n \u0111\u00e3 \u0111\u01b0\u1ee3c ti\u00eam v\u1eafc-xin cu\u0301m mu\u0300a n\u0103m ngo\u00e1i r\u1ed3i th\u00ec v\u1eafc-xin cu\u0303ng c\u00f3 th\u1ec3 kh\u00f4ng giu\u0301p b\u1ea1n kh\u00f4ng b\u1ecb cu\u0301m n\u0103m nay b\u1edfi h\u00e0m l\u01b0\u1ee3ng v\u1eafc-xin trong c\u01a1 th\u1ec3 b\u1ea1n \u0111\u00e3 y\u1ebfu \u0111i v\u00e0 vi-ru\u0301t cu\u0301m bi\u1ebfn \u0111\u1ed5i li\u00ean t\u1ee5c. \u0110\u00f3 l\u00e0 l\u00fd do v\u00ec sao v\u1eafc-xin ph\u1ea3i \u0111\u01b0\u1ee3c \u0111\u1ed5i m\u1edbi h\u00e0ng n\u0103m \u0111\u1ec3 k\u00e8m th\u00eam c\u00e1c gi\u1ed1ng vi-ru\u0301t m\u1edbi nh\u1ea5t. M\u1ed9t v\u00ed d\u1ee5 minh ho\u1ea1 r\u00f5 r\u00e0ng cho th\u1ea5y c\u00e1ch vi-ru\u0301t bi\u1ebfn \u0111\u1ed5i (v\u00e0 nhi\u1ec1u khi c\u00f2n ph\u00e1t tri\u1ec3n l\u00ean th\u00e0nh m\u1ed9t gi\u1ed1ng vi-ru\u0301t m\u1edbi) l\u00e0 \u0111\u1ee3t bu\u0300ng n\u1ed5 d\u1ecbch cu\u0301m H1N1 n\u0103m 2009. Lo\u1ea1i cu\u0301m n\u00e0y kh\u00f4ng thu\u1ed9c d\u1ea1ng ch\u1ee7ng ng\u1eeba trong v\u1eafc-xin cu\u0301m mu\u0300a n\u0103m 2009-2010, th\u1ebf n\u00ean ng\u01b0\u1eddi ta \u0111\u00e3 ph\u00e1t tri\u1ec3n th\u00eam m\u1ed9t v\u1eafc-xin cu\u0301m H1N1 ri\u00eang bi\u1ec7t n\u1eefa. T\u1eeb \u0111\u00f3, cu\u0301m H1N1 \u0111\u01b0\u1ee3c ti\u00eam k\u1ebft h\u1ee3p v\u1edbi mu\u0303i ti\u00eam cu\u0301m mu\u0300a.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra Th\u01b0\u1eddng th\u00ec v\u1eafc-xin ph\u00f2ng cu\u0301m n\u00e0y \u0111\u01b0\u1ee3c ch\u00edch \u1edf vu\u0300ng tr\u00ean c\u1ee7a c\u00e1nh tay, mu\u0303i ti\u00eam ng\u1eeba cu\u0301m ch\u1ee9a vi-ru\u0301t g\u00e2y cu\u0301m \u0111\u00e3 ch\u1ebft s\u1ebd kh\u00f4ng l\u00e0m cho ng\u01b0\u1eddi \u0111\u01b0\u1ee3c ti\u00eam ph\u00f2ng m\u1eafc b\u1ec7nh m\u00e0 s\u1ebd giu\u0301p cho c\u01a1 th\u1ec3 t\u1ea1o kh\u00e1ng th\u1ec3 ch\u1ed1ng l\u1ea1i vi-ru\u0301t cu\u0301m c\u00f2n s\u1ed1ng khi chu\u0301ng x\u00e2m nh\u1eadp v\u00e0o c\u01a1 th\u1ec3. M\u1ed9t s\u1ed1 t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng th\u1ea5y nh\u1ea5t khi ti\u00eam ng\u1eeba cu\u0301m l\u00e0 \u0111au nh\u1ee9c, n\u1ed5i \u0111\u1ecf ho\u1eb7c s\u01b0ng \u1edf vu\u0300ng ti\u00eam v\u00e0 \u0111\u00f4i khi cu\u0303ng x\u1ea3y ra tr\u01b0\u1eddng h\u1ee3p \u0111au nh\u1ee9c v\u00e0 s\u1ed1t nh\u1eb9. V\u00ec v\u1eafc-xin cu\u0301m d\u1ea1ng x\u1ecbt v\u00e0o mu\u0303i du\u0300ng vi-ru\u0301t c\u00f2n s\u1ed1ng n\u00ean n\u00f3 cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y ra c\u00e1c tri\u1ec7u ch\u1ee9ng gi\u1ed1ng nh\u01b0 cu\u0301m nh\u1eb9, bao g\u1ed3m s\u1ed5 mu\u0303i, nh\u1ee9c \u0111\u1ea7u, \u00f3i m\u1eeda, \u0111au nh\u1ee9c c\u01a1 v\u00e0 s\u1ed1t. R\u1ea5t hi\u1ebfm khi v\u1eafc-xin ph\u00f2ng cu\u0301m c\u00f3 th\u1ec3 g\u00e2y t\u00e1c d\u1ee5ng ph\u1ee5 nguy hi\u1ec3m nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba  Kh\u00f4ng n\u00ean ti\u00eam ng\u1eeba cu\u0301m mu\u0300a cho: * tre\u0309 s\u01a1 sinh d\u01b0\u1edbi 6 th\u00e1ng tu\u1ed5i  * ng\u01b0\u1eddi b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi tr\u1ee9ng v\u00e0 c\u00e1c s\u1ea3n ph\u1ea9m l\u00e0m t\u1eeb tr\u1ee9ng. B\u1ea1n n\u00ean cho b\u00e1c s\u0129 bi\u1ebft n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng tr\u01b0\u1edbc khi cho b\u00e9 ti\u00eam ng\u1eeba nh\u00e9. * ng\u01b0\u1eddi \u0111\u00e3 t\u1eebng b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi v\u1eafc-xin ti\u00eam ng\u1eeba cu\u0301m  * ng\u01b0\u1eddi b\u1ecb h\u1ed9i ch\u1ee9ng Guillain-Barr\u00e9 (GBS l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh hi\u1ebfm g\u1eb7p g\u00e2y \u1ea3nh  h\u01b0\u1edfng \u0111\u1ebfn th\u1ea7n kinh) * ng\u01b0\u1eddi b\u1ecb b\u1ec7nh n\u1eb7ng  Ch\u0103m s\u00f3c cho con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba  C\u00f3 th\u1ec3 du\u0300ng thu\u1ed1c acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o cho th\u00edch h\u1ee3p. M\u1ed9t v\u00e0i b\u00e1c s\u0129 khuy\u1ebfn ngh\u1ecb n\u00ean s\u1eed d\u1ee5ng m\u1ed9t li\u1ec1u ngay tr\u01b0\u1edbc khi ch\u1ee7ng ng\u1eeba. B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 du\u0300ng m\u1ed9t mi\u1ebfng gi\u1ebb \u01b0\u1edbt, \u1ea5m ho\u1eb7c m\u1ed9t mi\u1ebfng l\u00f3t \u1ea5m \u0111\u1ec3 gi\u1ea3m \u0111au. Nhu\u0301c nh\u00edch, c\u1eed \u0111\u1ed9ng tay ch\u00e2n \u1edf vu\u0300ng ti\u00eam cu\u0303ng th\u01b0\u1eddng c\u00f3 t\u00e1c d\u1ee5ng gi\u1ea3m \u0111au.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc l\u00e0 n\u00ean ho\u00e3n hay tr\u00e1nh ti\u00eam lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu sau khi ti\u00eam ng\u1eeba x\u1ea3y ra nhi\u1ec1u v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng, s\u1ed1t cao, ho\u1eb7c m\u1ed9t v\u1ea5n \u0111\u1ec1 b\u1eadn t\u00e2m n\u00e0o kh\u00e1c. MMR (s\u1edfi, quai b\u1ecb, ru-b\u00ea-la) V\u1eafc-xin MMR c\u00f3 t\u00e1c d\u1ee5ng ng\u1eeba s\u1edfi, quai b\u1ecb v\u00e0 ru-b\u00ea-la. Ti\u00eam ng\u1eeba MMR \u0111\u01b0\u1ee3c chia th\u00e0nh 2 li\u1ec1u. Li\u1ec1u \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c ti\u00eam \u1edf giai \u0111o\u1ea1n t\u1eeb 12 \u0111\u1ebfn 15 th\u00e1ng tu\u1ed5i; li\u1ec1u th\u1ee9 hai th\u01b0\u1eddng t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i. T\u1ea1i sao ph\u1ea3i n\u00ean khuy\u1ebfn ngh\u1ecb du\u0300ng v\u1eafc-xin s\u1edfi, quai b\u1ecb v\u00e0 ru-b\u00ea-la l\u00e0 nh\u1eefng b\u1ec7nh l\u00e2y nhi\u1ec5m c\u00f3 th\u1ec3 g\u00e2y b\u1ec7nh nghi\u00eam tr\u1ecdng. H\u01a1n 95% tr\u1ebb em \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba MMR c\u00f3 th\u1ec3 mi\u1ec5n nhi\u1ec5m v\u1edbi 3 b\u1ec7nh n\u00e0y su\u1ed1t \u0111\u1eddi.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng r\u1ea5t hi\u1ebfm khi x\u1ea3y ra; nh\u01b0ng cu\u0303ng c\u00f3 th\u1ec3 g\u00e2y \u1ea3nh h\u01b0\u1edfng x\u1ea5u t\u1eeb nh\u1eb9 \u0111\u1ebfn v\u1eeba ph\u1ea3i nh\u01b0 ph\u00e1t ban, s\u1ed1t, s\u01b0ng m\u00e1/ s\u01b0ng h\u00e0m, tai bi\u1ebfn ng\u1eadp m\u00e1u v\u00e0 \u0111au kh\u1edbp nh\u1eb9. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi gelatin ho\u1eb7c v\u1edbi kh\u00e1ng sinh neomycin th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9.  * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u v\u1eafc-xin MMR tr\u01b0\u1edbc * n\u1ebfu con b\u1ea1n m\u1edbi \u0111\u01b0\u1ee3c ti\u00eam gamma globulin ho\u1eb7c m\u1edbi \u0111\u01b0\u1ee3c truy\u1ec1n m\u00e1u th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9. * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb m\u1ed9t b\u1ec7nh n\u00e0o \u0111\u00f3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 l\u00e0 b\u1ecb ung th\u01b0 * n\u1ebfu con b\u1ea1n \u0111ang du\u0300ng thu\u1ed1c prednisone, steroids, ho\u1eb7c c\u00e1c thu\u1ed1c \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch kh\u00e1c  * n\u1ebfu con c\u1ee7a b\u1ea1n \u0111ang du\u0300ng ho\u00e1 tr\u1ecb li\u1ec7u ho\u1eb7c \u0111ang \u0111i\u1ec1u tr\u1ecb b\u1eb1ng b\u1ee9c x\u1ea1 * n\u1ebfu con b\u1ea1n t\u1eebng b\u1ecb ti\u1ec3u huy\u1ebft c\u1ea7u th\u1ea5p, b\u1ea1n h\u00e3y n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn v\u1edbi b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9 * ph\u1ee5 n\u1eef c\u00f3 thai n\u00ean \u0111\u1ee3i cho \u0111\u1ebfn khi sinh xong m\u1edbi c\u00f3 th\u1ec3 ti\u00eam ng\u1eeba v\u1eafc-xin Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba N\u1ebfu b\u00e9 b\u1ecb n\u1ed5i ban m\u00e0 kh\u00f4ng c\u00f3 tri\u1ec7u ch\u1ee9ng g\u00ec kh\u00e1c th\u00ec cu\u0303ng kh\u00f4ng c\u1ea7n thi\u1ebft ph\u1ea3i ch\u1eefa tr\u1ecb g\u00ec v\u00e0 n\u00f3 s\u1ebd t\u1ef1 kh\u1ecfi trong v\u00f2ng m\u1ed9t v\u00e0i ng\u00e0y. B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. N\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u b\u1ea1n n\u00ean s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p. Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc l\u00e0 c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh kh\u00f4ng ti\u00eam v\u1eafc-xin n\u1eefa * n\u1ebfu c\u00f3 v\u1ea5n \u0111\u1ec1 g\u00ec \u0111\u00f3 sau khi ti\u00eam ng\u1eeba xong B\u1ec7nh thu\u1ef7 \u0111\u1eadu  V\u1eafc-xin th\u1ee7y \u0111\u1eadu c\u00f3 t\u00e1c d\u1ee5ng ng\u1eeba th\u1ee7y \u0111\u1eadu \u2013 m\u1ed9t ch\u1ee9ng b\u1ec7nh do vi-ru\u0301t th\u01b0\u1eddng th\u1ea5y v\u00e0 r\u1ea5t hay l\u00e2y lan c\u1ee7a tr\u1ebb em. L\u1ecbch ch\u1ee7ng ng\u1eeba V\u1eafc-xin th\u1ee7y \u0111\u1eadu \u0111\u01b0\u1ee3c ti\u00eam \u1edf giai \u0111o\u1ea1n t\u1eeb 12 \u0111\u1ebfn 15 th\u00e1ng tu\u1ed5i v\u00e0 \u0111\u01b0\u1ee3c ti\u00eam nh\u1eafc l\u1ea1i t\u1eeb 4 \u0111\u1ebfn 6 tu\u1ed5i \u0111\u1ec3 ph\u00f2ng tr\u00e1nh th\u00eam cho b\u00e9. Tr\u1ebb d\u01b0\u1edbi 13 tu\u1ed5i ch\u01b0a b\u1ecb b\u1ec7nh th\u1ee7y \u0111\u1eadu cu\u0303ng c\u00f3 th\u1ec3 ti\u00eam lo\u1ea1i v\u1eafc-xin n\u00e0y v\u1edbi 2 li\u1ec1u ri\u00eang bi\u1ec7t c\u00e1ch nhau \u00edt nh\u1ea5t l\u00e0 3 th\u00e1ng. Tr\u1ebb t\u1eeb 13 tu\u1ed5i tr\u1edf l\u00ean ch\u01b0a b\u1ecb b\u1ec7nh th\u1ee7y \u0111\u1eadu ho\u1eb7c ch\u01b0a ti\u00eam ng\u1eeba v\u1eafc-xin th\u00ec cu\u0303ng c\u1ea7n ph\u1ea3i ti\u00eam 2 li\u1ec1u v\u1eafc-xin c\u00e1ch nhau \u00edt nh\u1ea5t l\u00e0 1 th\u00e1ng. T\u1ea1i sao ph\u1ea3i n\u00ean khy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin V\u1eafc-xin th\u1ee7y \u0111\u1eadu c\u00f3 t\u00e1c d\u1ee5ng ng\u0103n ng\u1eeba \u0111\u01b0\u1ee3c tr\u01b0\u1eddng h\u1ee3p b\u1ec7nh n\u1eb7ng \u1edf h\u1ea7u h\u1ebft tr\u1ebb em c\u00f3 ti\u00eam ch\u1ee7ng. V\u1eafc-xin c\u00f3 th\u1ec3 ph\u00f2ng tr\u00e1nh \u0111\u01b0\u1ee3c \u0111\u1ebfn 85% tr\u01b0\u1eddng h\u1ee3p b\u1ec7nh nhe. Nh\u1eefng tr\u1ebb em \u0111\u00e3 \u0111\u01b0\u1ee3c ch\u1ee7ng ng\u1eeba th\u01b0\u1eddng b\u1ecb thu\u1ef7 \u0111\u1eadu nh\u1eb9. R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c ph\u1ea3n \u1ee9ng nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng l\u00e0 r\u1ea5t hi\u1ebfm. C\u00f3 th\u1ec3 x\u1ea3y ra t\u00ecnh tr\u1ea1ng \u0111au nh\u1ee9c nh\u1eb9 v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam, s\u1ed1t, m\u1ec7t m\u1ecfi, v\u00e0 b\u1ec7nh gi\u1ed1ng nh\u01b0 thu\u1ef7 \u0111\u1eadu. Ch\u1ee9ng ph\u00e1t ban c\u00f3 th\u1ec3 x\u1ea3y ra 1 th\u00e1ng sau khi ti\u00eam; c\u00f3 th\u1ec3 k\u00e9o d\u00e0i v\u00e0i ng\u00e0y nh\u01b0ng s\u1ebd t\u1ef1 kh\u1ecfi m\u00e0 kh\u00f4ng c\u1ea7n ph\u1ea3i ch\u1eefa tr\u1ecb g\u00ec. R\u1ea5t hi\u1ebfm khi x\u1ea3y ra tai bi\u1ebfn ng\u1eadp m\u00e1u do s\u1ed1t sau khi ti\u00eam ng\u1eeba v\u1eafc-xin.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi gelatin ho\u1eb7c v\u1edbi kh\u00e1ng sinh neomycin  * n\u1ebfu con b\u1ea1n b\u1ecb ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi li\u1ec1u v\u1eafc-xin th\u1ee7y \u0111\u1eadu tr\u01b0\u1edbc * n\u1ebfu con b\u1ea1n m\u1edbi \u0111\u01b0\u1ee3c ti\u00eam gamma globulin ho\u1eb7c m\u1edbi \u0111\u01b0\u1ee3c truy\u1ec1n m\u00e1u, b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ti\u00eam ng\u1eeba cho b\u00e9 nh\u00e9 * n\u1ebfu con b\u1ea1n b\u1ecb b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u1ec7 mi\u1ec5n d\u1ecbch, nh\u01b0 l\u00e0 b\u1ecb ung th\u01b0 ch\u1eb3ng h\u1ea1n; n\u1ebfu b\u00e9 \u0111ang du\u0300ng prednisone, steroids, ho\u1eb7c c\u00e1c thu\u1ed1c \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch kh\u00e1c; ho\u1eb7c \u0111ang du\u0300ng ho\u00e1 tr\u1ecb li\u1ec7u ho\u1eb7c \u0111ang \u0111i\u1ec1u tr\u1ecb b\u1eb1ng b\u1ee9c x\u1ea1 * ph\u1ee5 n\u1eef c\u00f3 thai n\u00ean \u0111\u1ee3i cho \u0111\u1ebfn khi sinh xong m\u1edbi c\u00f3 th\u1ec3 ti\u00eam ng\u1eeba v\u1eafc-xin Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba  B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. N\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng lo\u1ea1i thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p. Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc l\u00e0 li\u1ec7u n\u00ean ho\u00e3n hay tr\u00e1nh ti\u00eam lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec sau khi ch\u1ee7ng ng\u1eeba MCV4 V\u1eafc-xin vi\u00eam m\u00e0ng n\u00e3o c\u00f3 t\u00e1c d\u1ee5ng ng\u0103n ng\u1eeba b\u1ec7nh do khu\u1ea9n c\u1ea7u m\u00e0ng n\u00e3o g\u00e2y ra, \u0111\u00e2y l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh nhi\u1ec5m khu\u1ea9n nghi\u00eam tr\u1ecdng c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn vi\u00eam m\u00e0ng n\u00e3o do vi khu\u1ea9n. V\u1eafc-xin \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 11 \u0111\u1ebfn 12 tu\u1ed5i, tr\u1ebb t\u1eeb 13 \u0111\u1ebfn 18 tu\u1ed5i ch\u01b0a \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng tr\u01b0\u1edbc \u0111\u00e2y v\u00e0 thi\u1ebfu ni\u00ean l\u1edbn tu\u1ed5i h\u01a1n s\u1eafp v\u00e0o \u0111\u1ea1i h\u1ecdc v\u00e0 s\u1ed1ng \u1edf m\u00f4i tr\u01b0\u1eddng t\u1eadp th\u1ec3 v\u00e0 nh\u1eefng ng\u01b0\u1eddi s\u1eafp nh\u1eadp ngu\u0303. V\u1eafc- xin n\u00e0y cu\u0303ng \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 2 \u0111\u1ebfn 10 tu\u1ed5i c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao. Khi b\u1ec7nh c\u00f2n ti\u1ebfp t\u1ee5c th\u00ec nh\u1eefng tr\u1ebb em n\u00e0y cu\u0303ng c\u1ea7n th\u00eam m\u1ed9t li\u1ec1u ti\u00eam nh\u1eafc sau m\u1ed9t v\u00e0i n\u0103m, tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i b\u00e9 khi \u0111\u01b0\u1ee3c ti\u00eam ch\u00edch mu\u0303i \u0111\u1ea7u ti\u00ean. T\u1ea1i sao ph\u1ea3i n\u00ean khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Vi\u00eam m\u00e0ng n\u00e3o do vi khu\u1ea9n l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh vi\u00eam m\u00e0ng b\u1ea3o v\u1ec7 n\u00e3o v\u00e0 tu\u1ef7 s\u1ed1ng, l\u00e0 m\u1ed9t b\u1ec7nh hi\u1ebfm g\u1eb7p nh\u01b0ng r\u1ea5t hay l\u00e2y lan c\u00f3 th\u1ec3 l\u00e2y lan nhanh t\u1eeb tr\u1ebb n\u00e0y sang tr\u1ebb kh\u00e1c trong vu\u0300ng l\u00e2n c\u1eadn. B\u1ec7nh n\u00e0y c\u00f3 th\u1ec3 nguy hi\u1ec3m \u0111\u1ebfn t\u00ednh m\u1ea1ng n\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c ch\u1eefa tr\u1ecb k\u1ecbp th\u1eddi.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra M\u1ed9t s\u1ed1 t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng th\u1ea5y nh\u1ea5t l\u00e0 da b\u1ecb s\u01b0ng, n\u1ed5i \u0111\u1ecf v\u00e0 \u0111au nh\u1ee9c \u1edf vu\u0300ng ti\u00eam, cu\u0300ng v\u1edbi tri\u1ec7u ch\u1ee9ng nh\u1ee9c \u0111\u1ea7u, s\u1ed1t, ho\u1eb7c m\u1ec7t m\u1ecfi. C\u00e1c v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng r\u1ea5t hi\u1ebfm x\u1ea3y ra. Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111\u00e3 t\u1eebng ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin DtaP ho\u1eb7c d\u1ecb \u1ee9ng v\u1edbi nh\u1ef1a m\u1ee7 * n\u1ebfu con b\u1ea1n c\u00f3 ti\u1ec1n s\u1eed h\u1ed9i ch\u1ee9ng Guillain-Barr\u00e9, \u0111\u00e2y l\u00e0 m\u1ed9t ch\u1ee9ng b\u1ec7nh c\u1ee7a h\u1ec7 th\u1ea7n kinh l\u00e0m k\u00e9m ph\u00e1t tri\u1ec3n  * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba Con b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb s\u1ed1t, \u0111au nh\u1ee9c ho\u1eb7c da b\u1ecb s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. B\u1ea1n c\u00f3 th\u1ec3 cho b\u00e9 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. H\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u n\u00ean s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p nh\u00e9.  B\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 gi\u1ea3m \u0111au b\u1eb1ng m\u1ed9t mi\u1ebfng gi\u1ebb \u01b0\u1edbt, \u1ea5m. Nhu\u0301c nh\u00edch, c\u1eed \u0111\u1ed9ng tay ch\u00e2n vu\u0300ng ti\u00eam cu\u0303ng th\u01b0\u1eddng giu\u0301p gi\u1ea3m \u0111au nh\u1ee9c.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft li\u1ec7u n\u00ean ho\u00e3n hay tr\u00e1nh ti\u00eam lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec sau khi ti\u00eam ng\u1eeba B\u1ec7nh vi\u00eam gan si\u00eau vi A Vi-ru\u0301t vi\u00eam gan si\u00eau vi A (HAV) g\u00e2y ra s\u1ed1t, bu\u1ed3n n\u00f4n, \u00f3i m\u1eeda, v\u00e0ng da, v\u00e0 c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn \u0111\u1ea1i d\u1ecbch trong c\u1ed9ng \u0111\u1ed3ng. Nh\u1eefng trung t\u00e2m ch\u0103m s\u00f3c v\u00e0 gi\u00e1m s\u00e1t tr\u1ebb em th\u01b0\u1eddng l\u00e0 n\u01a1i bu\u0300ng ph\u00e1t b\u1ec7nh vi\u00eam gan si\u00eau vi A.  V\u1eafc-xin vi\u00eam gan si\u00eau vi A \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 12 \u0111\u1ebfn 23 th\u00e1ng tu\u1ed5i v\u00e0 ti\u00eam th\u00eam li\u1ec1u th\u1ee9 hai sau 6 th\u00e1ng. M\u1eb7c du\u0300 lu\u0301c tr\u01b0\u1edbc lo\u1ea1i v\u1eafc-xin n\u00e0y \u0111\u01b0\u1ee3c khuy\u1ebfn c\u00e1o cho tr\u1ebb l\u1edbn tu\u1ed5i h\u01a1n v\u00e0 ng\u01b0\u1eddi l\u1edbn c\u00f3 nguy c\u01a1 nhi\u1ec5m b\u1ec7nh cao (nh\u01b0 ng\u01b0\u1eddi s\u1ed1ng ho\u1eb7c \u0111\u1ebfn c\u00e1c vu\u0300ng c\u00f3 t\u1ec9 l\u1ec7 ng\u01b0\u1eddi m\u1eafc HAV cao), ng\u00e0y nay v\u1eafc-xin n\u00e0y \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho t\u1ea5t c\u1ea3 m\u1ecdi ng\u01b0\u1eddi c\u00f3 nhu c\u1ea7u mu\u1ed1n mi\u1ec5n d\u1ecbch v\u1edbi b\u1ec7nh. T\u1ea1i sao ph\u1ea3i n\u00ean khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Ti\u00eam ng\u1eeba HAV kh\u00f4ng nh\u1eefng giu\u0301p ng\u0103n ch\u1eb7n d\u1ecbch b\u1ec7nh lan r\u1ed9ng trong c\u1ed9ng \u0111\u1ed3ng m\u00e0 c\u00f2n giu\u0301p ph\u00f2ng tr\u00e1nh b\u1ec7nh cho t\u1eebng \u0111\u1ee9a tr\u1ebb m\u1ed9t. M\u1ed9t s\u1ed1 tr\u1ebb b\u1ecb nhi\u1ec5m b\u1ec7nh kh\u00f4ng c\u00f3 b\u1ea5t k\u1ef3 tri\u1ec7u ch\u1ee9ng g\u00ec v\u00e0 c\u00f3 th\u1ec3 l\u00e2y vi-ru\u0301t cho nh\u1eefng \u0111\u1ee9a tr\u1ebb kh\u00e1c. c\u00e0ng nhi\u1ec1u tr\u1ebb em \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng HAV th\u00ec b\u1ec7nh s\u1ebd \u00edt l\u00e2y lan trong c\u1ed9ng \u0111\u1ed3ng h\u01a1n.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p l\u00e0 s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c, da b\u1ecb s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. R\u1ea5t hi\u1ebfm khi x\u1ea3y ra tr\u01b0\u1eddng h\u1ee3p ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi li\u1ec1u v\u1eafc-xin vi\u00eam gan si\u00eau vi A \u0111\u1ea7u ti\u00ean  Ch\u0103m s\u00f3c con b\u1ea1n sau khi ti\u00eam ng\u1eeba Con b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb s\u1ed1t, \u0111au nh\u1ee9c, da b\u1ecb s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. N\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p cho b\u00e9 nh\u00e9.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129 * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh ch\u1ee7ng ng\u1eeba v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec \u0111\u00f3 sau khi ch\u1ee7ng ng\u1eeba Vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y Vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y l\u00e0 vi-ru\u0301t th\u01b0\u1eddng th\u1ea5y g\u00e2y b\u1ec7nh ti\u00eau ch\u1ea3y, nh\u1ea5t l\u00e0 \u0111\u1ed1i v\u1edbi tr\u1ebb s\u01a1 sinh v\u00e0 tr\u1ebb nh\u1ecf. C\u00e1c trung t\u00e2m ch\u0103m s\u00f3c v\u00e0 gi\u00e1m s\u00e1t tr\u1ebb em th\u01b0\u1eddng l\u00e0 nh\u1eefng n\u01a1i bu\u0300ng ph\u00e1t d\u1ecbch b\u1ec7nh. V\u1eafc-xin n\u00e0y \u1edf d\u1ea1ng ch\u1ea5t l\u1ecfng v\u00e0 \u0111\u01b0\u1ee3c du\u0300ng \u0111\u01b0\u1eddng u\u1ed1ng; \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho tr\u1ebb t\u1eeb 2 \u0111\u1ebfn 4 th\u00e1ng tu\u1ed5i, cu\u0303ng nh\u01b0 1 li\u1ec1u \u1edf giai \u0111o\u1ea1n 6 th\u00e1ng tu\u1ed5i tu\u1ef3 thu\u1ed9c v\u00e0o lo\u1ea1i v\u1eafc-xin \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba.  T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin Vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y c\u00f3 th\u1ec3 g\u00e2y m\u1ea5t n\u01b0\u1edbc th\u1ee9 ph\u00e1t \u0111\u1ebfn ti\u00eau ch\u1ea3y n\u1eb7ng v\u00e0 c\u00f3 th\u1ec3 b\u1eaft tr\u1ebb ph\u1ea3i nh\u1eadp vi\u1ec7n. Vi\u1ec7c ch\u1ee7ng ng\u1eeba vi ru\u0301t g\u00e2y b\u1ec7nh vi\u00eam ru\u1ed9t v\u00e0 d\u1ea1 d\u00e0y c\u00f3 th\u1ec3 giu\u0301p ng\u0103n ch\u1eb7n l\u00e2y lan trong c\u1ed9ng \u0111\u1ed3ng v\u00e0 giu\u0301p ph\u00f2ng tr\u00e1nh b\u1ec7nh cho t\u1eebng tr\u1ebb m\u1ed9t.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p l\u00e0 ti\u00eau ch\u1ea3y, \u00f3i m\u1eeda v\u00e0 s\u1ed1t.  K hi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 th\u00ec cu\u0303ng kh\u00f4ng n\u00ean ch\u1ee7ng ng\u1eeba * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi li\u1ec1u v\u1eafc-xin tr\u01b0\u1edbc * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb \u1ee9ng v\u1edbi nh\u1ef1a m\u1ee7 th\u00ec b\u1ea1n n\u00ean th\u00f4ng b\u00e1o cho b\u00e1c s\u0129 bi\u1ebft  * n\u1ebfu con b\u1ea1n b\u1ecb d\u1ecb t\u1eadt v\u1ec1 h\u1ec7 ti\u00eau ho\u00e1 ho\u1eb7c b\u1ec7nh d\u1ea1 d\u00e0y-ru\u1ed9t th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 nh\u00e9 * n\u1ebfu con b\u1ea1n c\u00f3 ti\u1ec1n s\u1eed l\u1ed3ng ru\u1ed9t, m\u1ed9t b\u1ec7nh t\u1eaft ngh\u1ebdn ru\u1ed9t nghi\u00eam tr\u1ecdng th\u00ec b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 v\u1ec1 vi\u1ec7c ch\u1ee7ng ng\u1eeba cho b\u00e9 * n\u1ebfu con b\u1ea1n m\u1edbi \u0111\u01b0\u1ee3c ti\u00eam gamma globulin ho\u1eb7c m\u1edbi \u0111\u01b0\u1ee3c truy\u1ec1n m\u00e1u * n\u1ebfu con b\u1ea1n c\u00f3 v\u1ea5n \u0111\u1ec1 v\u1ec1 h\u1ec7 mi\u1ec5n d\u1ecbch nh\u01b0 b\u1ecb ung th\u01b0 ch\u1eb3ng h\u1ea1n; n\u1ebfu b\u00e9 \u0111ang du\u0300ng thu\u1ed1c steroid hay c\u00e1c thu\u1ed1c \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch kh\u00e1c; ho\u1eb7c b\u00e9 \u0111ang du\u0300ng ho\u00e1 tr\u1ecb li\u1ec7u ho\u1eb7c \u0111ang \u0111i\u1ec1u tr\u1ecb b\u1eb1ng b\u1ee9c x\u1ea1 Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba Tu\u1ef3 v\u00e0o \u0111\u1ed9 tu\u1ed5i c\u1ee7a con b\u1ea1n m\u00e0 b\u00e1c s\u0129 c\u00f3 th\u1ec3 cho acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t. H\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 bi\u1ebft xem c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p. N\u1ebfu b\u00e9 b\u1ecb \u00f3i m\u1eeda ho\u1eb7c ti\u00eau ch\u1ea3y th\u00ec ph\u1ea3i \u0111\u1ea3m b\u1ea3o n\u00ean cho b\u00e9 u\u1ed1ng n\u01b0\u1edbc th\u01b0\u1eddng xuy\u00ean v\u00e0 theo d\u00f5i xem b\u00e9 c\u00f3 d\u1ea5u hi\u1ec7u m\u1ea5t n\u01b0\u1edbc kh\u00f4ng, ch\u1eb3ng h\u1ea1n nh\u01b0 n\u01b0\u1edbc ti\u1ec3u \u00edt h\u01a1n b\u00ecnh th\u01b0\u1eddng.  Khi n\u00e0o n\u00ean g\u1ecdi \u0111i\u1ec7n cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh ch\u1ee7ng ng\u1eeba lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec \u0111\u00f3 sau khi ch\u1ee7ng ng\u1eeba HPV Vi-ru\u0301t g\u00e2y b\u1ec7nh m\u1ee5n c\u01a1m tr\u00ean ng\u01b0\u1eddi (HPV) l\u00e0 b\u1ec7nh l\u00e2y truy\u1ec1n qua \u0111\u01b0\u1eddng t\u00ecnh d\u1ee5c (STD) g\u00e2y n\u1ed5i m\u1ee5n c\u00f3c \u1edf b\u1ed9 ph\u1eadn sinh d\u1ee5c v\u00e0 g\u00e2y ra nh\u1eefng thay \u0111\u1ed5i trong c\u1ed5 t\u1eed cung c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn ung th\u01b0 c\u1ed5 t\u1eed cung. V\u1eafc-xin \u0111\u01b0\u1ee3c ti\u00eam ng\u1eeba th\u00e0nh m\u1ed9t lo\u1ea1t 3 mu\u0303i trong v\u00f2ng 6 th\u00e1ng v\u00e0 \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng cho b\u00e9 g\u00e1i t\u1eeb 11 ho\u1eb7c 12 tu\u1ed5i, cu\u0303ng nh\u01b0 c\u00e1c b\u00e9 g\u00e1i l\u1edbn tu\u1ed5i h\u01a1n ch\u01b0a \u0111\u01b0\u1ee3c ti\u00eam ch\u1ee7ng. Lo\u1ea1i v\u1eafc-xin n\u00e0y cu\u0303ng \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng cho b\u00e9 trai t\u1eeb 9 \u0111\u1ebfn 18 tu\u1ed5i nh\u1eb1m ph\u00f2ng tr\u00e1nh ch\u1ee9ng n\u1ed5i m\u1ee5n c\u00f3c \u1edf b\u1ed9 ph\u1eadn sinh d\u1ee5c. T\u1ea1i sao ph\u1ea3i khuy\u1ebfn ngh\u1ecb s\u1eed d\u1ee5ng v\u1eafc-xin  V\u00ec vi-ru\u0301t HPV c\u00f3 th\u1ec3 g\u00e2y nhi\u1ec1u v\u1ea5n \u0111\u1ec1 nghi\u00eam tr\u1ecdng nh\u01b0 n\u1ed5i m\u1ee5n c\u00f3c \u1edf b\u1ed9 ph\u1eadn sinh d\u1ee5c v\u00e0 ung th\u01b0 c\u1ed5 t\u1eed cung, n\u00ean v\u1eafc-xin l\u00e0 m\u1ed9t bi\u1ec7n ph\u00e1p quan tr\u1ecdng nh\u1eb1m ph\u00f2ng tr\u00e1nh l\u00e2y nhi\u1ec5m v\u00e0 ng\u0103n ng\u1eeba l\u00e2y lan HPV. V\u1eafc-xin n\u00e0y c\u00f3 hi\u1ec7u qu\u1ea3 t\u1ed1t nh\u1ea5t n\u1ebfu ti\u00eam ng\u1eeba cho b\u00e9 g\u00e1i tr\u01b0\u1edbc khi quan h\u1ec7 t\u00ecnh d\u1ee5c.  R\u1ee7i ro c\u00f3 th\u1ec3 x\u1ea3y ra C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u01b0\u1eddng g\u1eb7p l\u00e0 s\u1ed1t nh\u1eb9, \u0111au nh\u1ee9c, da s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam; cu\u0303ng c\u00f3 th\u1ec3 b\u1ecb ch\u00f3ng m\u1eb7t, cho\u00e1ng v\u00e1ng, bu\u1ed3n n\u00f4n v\u00e0 \u00f3i m\u1eeda sau khi ti\u00eam ng\u1eeba. Tr\u01b0\u1eddng h\u1ee3p d\u1ecb \u1ee9ng v\u1edbi v\u1eafc-xin r\u1ea5t hi\u1ebfm khi x\u1ea3y ra.  Khi n\u00e0o n\u00ean ho\u00e3n ho\u1eb7c tr\u00e1nh ch\u1ee7ng ng\u1eeba * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111ang b\u1ecb b\u1ec7nh, m\u1eb7c du\u0300 l\u00e0 c\u1ea3m nh\u1eb9 ho\u1eb7c b\u1ecb m\u1ed9t b\u1ec7nh nh\u1eb9 n\u00e0o kh\u00e1c th\u00ec cu\u0303ng n\u00ean tr\u00e1nh ch\u00edch ng\u1eeba * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111\u00e3 b\u1ecb d\u1ecb \u1ee9ng v\u1edbi li\u1ec1u v\u1eafc-xin HPV \u0111\u1ea7u ti\u00ean * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111\u00e3 b\u1ecb d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi men (r\u01b0\u1ee3u bia) * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n \u0111ang c\u00f3 thai * n\u1ebfu con g\u00e1i c\u1ee7a b\u1ea1n b\u1ecb b\u1ec7nh m\u00e1u lo\u00e3ng (b\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 chuy\u00ean khoa huy\u1ebft h\u1ecdc nh\u00e9) Ch\u0103m s\u00f3c con b\u1ea1n sau khi ch\u1ee7ng ng\u1eeba Con c\u1ee7a b\u1ea1n c\u00f3 th\u1ec3 b\u1ecb s\u1ed1t, \u0111au nh\u1ee9c, da s\u01b0ng v\u00e0 n\u1ed5i \u0111\u1ecf \u1edf vu\u0300ng ti\u00eam. B\u1ea1n c\u00f3 th\u1ec3 du\u0300ng acetaminophen ho\u1eb7c ibuprofen \u0111\u1ec3 gi\u1ea3m \u0111au v\u00e0 h\u1ea1 s\u1ed1t cho b\u00e9. H\u00e3y tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 xem li\u1ec7u c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng thu\u1ed1c g\u00ec v\u00e0 li\u1ec1u l\u01b0\u1ee3ng nh\u01b0 th\u1ebf n\u00e0o l\u00e0 th\u00edch h\u1ee3p.  Khi n\u00e0o n\u00ean g\u1ecdi cho b\u00e1c s\u0129  * n\u1ebfu b\u1ea1n kh\u00f4ng bi\u1ebft ch\u1eafc li\u1ec7u c\u00f3 n\u00ean ho\u00e3n hay tr\u00e1nh ch\u1ee7ng ng\u1eeba lo\u1ea1i v\u1eafc-xin \u0111\u00f3 * n\u1ebfu x\u1ea3y ra v\u1ea5n \u0111\u1ec1 g\u00ec sau khi ch\u1ee7ng ng\u1eeba L\u1ecbch ch\u1ee7ng ng\u1eeba L\u1ecbch ch\u1ee7ng ng\u1eeba n\u00e0y l\u00e0 b\u1ea3ng tham kh\u1ea3o ti\u1ec7n l\u1ee3i c\u00f3 th\u1ec3 giu\u0301p cho b\u1ea1n theo d\u00f5i \u0111\u01b0\u1ee3c c\u00e1c lo\u1ea1i v\u1eafc-xin c\u1ea7n thi\u1ebft v\u1edbi con m\u00ecnh v\u00e0 th\u1eddi gian ti\u00eam ng\u1eeba cho b\u00e9.  C\u00e1c lo\u1ea1i v\u1eafc-xin M\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin th\u01b0\u1eddng g\u1eb7p: 1. Vi-ru\u0301t c\u00f2n s\u1ed1ng nh\u01b0ng \u0111\u00e3 b\u1ecb l\u00e0m y\u1ebfu \u0111i \u0111\u01b0\u1ee3c du\u0300ng trong m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin nh\u01b0 v\u1eafc-xin s\u1edfi, ru-b\u00ea-la v\u00e0 quai b\u1ecb.  2. Vi-ru\u0301t ho\u1eb7c vi khu\u1ea9n \u0111\u00e3 ch\u1ebft (ho\u1eb7c b\u1ea5t ho\u1ea1t) \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng trong m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin nh\u01b0 v\u1eafc-xin IPV. 3. V\u1eafc-xin gi\u1ea3i \u0111\u1ed9c t\u1ed1 ch\u1ee9a \u0111\u1ed9c t\u1ed1 t\u00f4-xin b\u1ea5t ho\u1ea1t do vi khu\u1ea9n t\u1ea1o ra. Ch\u1eb3ng h\u1ea1n nh\u01b0 v\u1eafc-xin b\u1ea1ch h\u1ea7u v\u00e0 u\u1ed1n v\u00e1n l\u00e0 c\u00e1c v\u1eafc-xin gi\u1ea3i \u0111\u1ed9c t\u1ed1. 4. V\u1eafc-xin k\u1ebft h\u1ee3p (nh\u01b0 Hib) ch\u1ee9a c\u00e1c th\u00e0nh ph\u1ea7n vi khu\u1ea9n k\u1ebft h\u1ee3p v\u1edbi pr\u00f4-t\u00ea-in. Ch\u1ee7ng ng\u1eeba khi \u0111i du l\u1ecbch C\u00e1c Trung t\u00e2m ph\u00f2ng ch\u1ed1ng b\u1ec7nh t\u1eadt (CDC) s\u1ebd cung c\u1ea5p tr\u1ef1c ti\u1ebfp th\u00f4ng tin c\u1ee5 th\u1ec3 v\u1ec1 ch\u1ee7ng ng\u1eeba cho kh\u00e1ch du l\u1ecbch \u0111\u1ebfn t\u1eebng qu\u1ed1c gia tr\u00ean to\u00e0n c\u1ea7u. B\u1ea1n n\u00ean tham kh\u1ea3o \u00fd ki\u1ebfn c\u1ee7a b\u00e1c s\u0129 \u0111\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin nh\u00e9. Tu\u0300y thu\u1ed9c v\u00e0o lo\u1ea1i h\u00ecnh du l\u1ecbch v\u00e0 th\u1eddi gian \u0111i du l\u1ecbch m\u00e0 ng\u01b0\u1eddi ta khuy\u1ebfn ngh\u1ecb n\u00ean s\u1eed d\u1ee5ng m\u1ed9t s\u1ed1 lo\u1ea1i v\u1eafc-xin. H\u1ea7u h\u1ebft c\u00e1c v\u1eafc-xin ch\u1ee7ng ng\u1eeba \u0111\u1ec1u \u0111\u01b0\u1ee3c ti\u00eam tr\u01b0\u1edbc khi \u0111i du l\u1ecbch \u00edt nh\u1ea5t l\u00e0 1 th\u00e1ng. B\u1ea1n n\u00ean mang theo h\u1ed3 s\u01a1 ch\u1ee7ng ng\u1eeba c\u1ee7a b\u00e9 b\u1ea5t k\u1ec3 khi n\u00e0o b\u1ea1n \u0111i du l\u1ecbch qu\u1ed1c t\u1ebf nh\u00e9. Giu\u0301p tr\u1ebb v\u01b0\u1ee3t qua n\u1ed7i s\u1ee3 h\u00e3i ch\u1ee7ng ng\u1eeba Nhi\u1ec1u khi kh\u00f3 bi\u1ebft \u0111\u01b0\u1ee3c gi\u1eefa b\u1ed1 m\u1eb9 v\u00e0 tr\u1ebb con - ai l\u00e0 ng\u01b0\u1eddi s\u1ee3 ch\u1ee7ng ng\u1eeba h\u01a1n. D\u01b0\u1edbi \u0111\u00e2y l\u00e0 m\u1ed9t s\u1ed1 b\u00ed quy\u1ebft giu\u0301p cho quy tr\u00ecnh ti\u00eam ch\u1ee7ng tr\u1edf n\u00ean d\u1ec5 d\u00e0ng cho t\u1ea5t c\u1ea3 m\u1ecdi ng\u01b0\u1eddi. * H\u00e3y n\u00f3i cho nh\u1eefng tr\u1ebb l\u1edbn tu\u1ed5i h\u01a1n bi\u1ebft chuy\u1ec7n g\u00ec s\u1ebd x\u1ea3y ra v\u00e0 ti\u00eam ng\u1eeba c\u00f3 th\u1ec3 giu\u0301p chu\u0301ng kho\u1ebb m\u1ea1nh h\u01a1n * H\u00e3y n\u00f3i v\u1edbi tr\u1ebb nh\u1ecf l\u00e0 n\u1ebfu b\u00e9 kh\u00f3c th\u00ec cu\u0303ng \u0111\u01b0\u1ee3c th\u00f4i nh\u01b0ng b\u1ea1n cu\u0303ng n\u00ean khuy\u1ebfn kh\u00edch chu\u0301ng h\u00e3y can \u0111\u1ea3m l\u00ean. * B\u1ea1n h\u00e3y t\u1ecf ra b\u00ecnh t\u0129nh nh\u00e9. Con c\u1ee7a b\u1ea1n cu\u0303ng c\u00f3 th\u1ec3 \u0111\u1ec3 \u00fd \u0111\u01b0\u1ee3c m\u1ed1i lo l\u1eafng c\u1ee7a b\u1ea1n \u0111\u1ea5y. * Vi\u1ec7c l\u00e0m cho b\u00e9 ph\u00e2n t\u00e2m lu\u0301c n\u00e0y cu\u0303ng c\u00f3 t\u00e1c d\u1ee5ng t\u1ed1t. B\u1ea1n h\u00e3y th\u1eed cho b\u00e9 \u0111\u1ebfm, cu\u0300ng h\u00e1t m\u1ed9t b\u00e0i h\u00e1t v\u1edbi b\u1ea1n, ho\u1eb7c nh\u00ecn sang ch\u1ed7 kh\u00e1c (c\u00f3 th\u1ec3 nh\u00ecn m\u1ed9t b\u1ee9c tranh tr\u00ean t\u01b0\u1eddng). B\u1ea1n cu\u0303ng n\u00ean chu\u1ea9n b\u1ecb s\u1eb5n m\u1ed9t chuy\u1ec7n \u0111u\u0300a ho\u1eb7c m\u1ed9t l\u1eddi n\u00f3i d\u00ed d\u1ecfm n\u00e0o \u0111\u00f3 cho b\u00e9 nh\u00e9. * H\u00e3y khen b\u00e9 sau khi \u0111\u00e3 ti\u00eam ng\u1eeba xong. * B\u1ea1n n\u00ean chu\u1ea9n b\u1ecb m\u1ed9t vi\u1ec7c g\u00ec \u0111\u00f3 vui v\u1ebb sau khi b\u00e9 ch\u00edch ng\u1eeba xong. M\u1ed9t chuy\u1ebfn \u0111i c\u00f4ng vi\u00ean hay ch\u01a1i \u1edf s\u00e2n ch\u01a1i cu\u0303ng c\u00f3 th\u1ec3 l\u00e0m cho cu\u1ed9c ti\u00eam ng\u1eeba tr\u1edf n\u00ean d\u1ec5 ch\u1ecbu h\u01a1n.  Vi\u1ec7c ti\u00eam ch\u1ee7ng c\u00f3 th\u1ec3 khi\u1ebfn cho c\u1ea3 b\u1ea1n v\u00e0 con b\u1ea1n c\u1ea3m th\u1ea5y kh\u00f4ng tho\u1ea3i m\u00e1i t\u00ed n\u00e0o, nh\u01b0ng xin nh\u1edb r\u1eb1ng ch\u1ee7ng ng\u1eeba l\u00e0 m\u1ed9t trong nh\u1eefng bi\u1ec7n ph\u00e1p b\u1ea3o v\u1ec7 t\u1ed1t nh\u1ea5t giu\u0301p ph\u00f2ng tr\u00e1nh c\u00e1c b\u1ec7nh l\u00e2y nhi\u1ec5m."
        }
    ],
    "suggestions": []
}